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Abstract
During the last few years, research on toxicologically relevant properties of engineered nanoparticles has increased
tremendously. A number of international research projects and additional activities are ongoing in the EU and the US,
nourishing the expectation that more relevant technical and toxicological data will be published. Their widespread use
allows for potential exposure to engineered nanoparticles during the whole lifecycle of a variety of products. When
looking at possible exposure routes for manufactured Nanoparticles, inhalation, dermal and oral exposure are the most
obvious, depending on the type of product in which Nanoparticles are used. This review shows that (1) Nanoparticles
can deposit in the respiratory tract after inhalation. For a number of nanoparticles, oxidative stress-related inflammatory
reactions have been observed. Tumour-related effects have only been observed in rats, and might be related to overload
conditions. There are also a few reports that indicate uptake of nanoparticles in the brain via the olfactory epithelium.
Nanoparticle translocation into the systemic circulation may occur after inhalation but conflicting evidence is present on
the extent of translocation. These findings urge the need for additional studies to further elucidate these findings and to
characterize the physiological impact. (2) There is currently little evidence from skin penetration studies that dermal
applications of metal oxide nanoparticles used in sunscreens lead to systemic exposure. However, the question has been
raised whether the usual testing with healthy, intact skin will be sufficient. (3) Uptake of nanoparticles in the
gastrointestinal tract after oral uptake is a known phenomenon, of which use is intentionally made in the design of food
and pharmacological components. Finally, this review indicates that only few specific nanoparticles have been investigated
in a limited number of test systems and extrapolation of this data to other materials is not possible. Air pollution studies
have generated indirect evidence for the role of combustion derived nanoparticles (CDNP) in driving adverse health
effects in susceptible groups. Experimental studies with some bulk nanoparticles (carbon black, titanium dioxide, iron
oxides) that have been used for decades suggest various adverse effects. However, engineered nanomaterials with new
chemical and physical properties are being produced constantly and the toxicity of these is unknown. Therefore, despite
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the existing database on nanoparticles, no blanket statements about human toxicity can be given at this time. In addition,
limited ecotoxicological data for nanomaterials precludes a systematic assessment of the impact of Nanoparticles on
ecosystems.
1) Background
1.1 Definitions
Nanotechnology is considered by many as the next logical
step in science, integrating engineering with biology,
chemistry and physics [1]. It derives from the ongoing
trend for miniaturisation in technology as described by
Moore's Law and combination with other disciplines.
Miniaturisation however has its limits and new
approaches in manufacturing (bottom-up fabrication)
have to be developed to reach anticipated milestones.
Nanotechnology can be considered as the application of
science that "steps across the limit" of miniaturisation,
where" new rules" become valid [2] More specifically,
when the dimensions of a piece of solid material become
very small, its physical and chemical properties can
become very different from those of the same material in
larger bulk form. This is one of the hallmarks of Nanote-
chnology, which can be described as a research area in
which this limit of new properties is reached and strategies
are developed to exploit the regime of size-controlled
properties.
In the last couple of years, the term Nanotechnology has
been inflated and has almost become synonymous for
things that are innovative and highly promising. On the
other hand it is also the subject of considerable debate
regarding the open question on toxicological and envi-
ronmental impact of Nanoparticles and nanotubes [3,4].
In this discussion a definition of Nanotechnology and its
underlying sectors, applications and markets is important
for the purpose of risk assessment and risk communica-
tion. Many definitions refer to the length scale (nano) of
this new science but not all mention the new functionali-
ties of materials and components at the nanoscale. A com-
monly-used working definition refers to the size and
(changing) properties of materials in the size range
between 1 nanometre (10 ) and 100 nm, but this gives rise
to many uncertainties and inconsistencies which need to
be resolved.
Although quite open and abstract the recent definition
forwarded by a working group of the Europische Akade-
mie [2] states:
"Nanotechnology is dealing with functional systems based on
the use of sub-units with specific size dependent properties of the
individual sub-units or of a system of those"
The report by the Royal Society and Royal Academy of
Engineering [5] gives the following definitions of 'nano-
science' and 'nanotechnologies':
"Nanoscience is the study of phenomena and manipulation of
materials at atomic, molecular and macromolular scales, where
the properties differ significantly from those at a larger scale";
"Nanotechnologies are the design, characterisation, production
and application of structures, devices and systems by controlling
shape and size at nanometre scale".
Other definitions are more specific, such as the one used
by Nanoforum:
Nanotechnology is made up of areas of technology where
dimensions and tolerances in the range of 0.1 nm to 100 nm
play a critical role
Or very simple, as defined by [6]Nanotechnology – the
manipulation, precision placement, measurement, modelling or
manufacture of sub-100 nanometre scale matter.
1.2 Major applications and markets in nanotechnology
The nanotechnology market can be broadly divided into
3 segments, viz. Materials, Tools and Devices:
1. Nanomaterials – used to describe materials with one or
more components that have at least one dimension in the
range of 1 to 100 nm and include Nanoparticles, nanofi-
bres and nanotubes, composite materials and nano-struc-
tured surfaces. These include Nanoparticles (NP) as a
subset of nanomaterials currently defined by consensus as
single particles with a diameter < 100 nm. Agglomerates
of NP can be larger than 100 nm in diameter but will be
included in the discussion since they may break down on
weak mechanical forces or in solvents. Nanofibres are a
sub-class of nanoparticles (include nanotubes) which
have two dimensions <100 nm but the third (axial)
dimension can be much larger.
2. Nanotools – tools and techniques for synthesising
nanomaterials, manipulating atoms and fabricating
device structures, and – very importantly – for measuring
and characterising materials and devices at the nanoscale;
3. Nanodevices – making devices at the nanoscale, impor-
tant in microelectronics and optoelectronics at the present
time, and at the interface with biotechnology where the
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aim is to mimic the action of biological systems such as
cellular motors. This latter area is the most futuristic, and
excites the greatest public reaction.
This report will primarily focus on the risks of manufac-
tured Nanoparticles and nanofibres, because this area of
nanotechnology should achieve volume production in
the near term and it is also the aspect that raises greatest
public concern about potential risks to health. However
the distinction from composite nanomaterials and tools
and devices becomes vague when nanoscale materials are
combined for medical applications. In the nearer term,
certain Nanoparticles offer opportunities to develop
smart drug delivery vehicles that can move through the
body to target sites, or sensor and diagnostic systems oper-
ating inside cells. Nanomaterials could also be used to
synthesise structures for implant into the body that have
properties that closely resemble the properties of natural
materials. Tissue scaffolds that use biocompatible nano-
materials to control cell growth and adhesion are under
development, and in the future artificial organs that
mimic the porosity and capillary structure of natural
organs such as the heart and liver may become reality [7].
These applications are not the subject of this study, but a
working group of the European Science Foundation on
this subject [7]. Nanomaterials constitute by far the most
significant market opportunity in the foreseeable future. A
2002 market survey forecasts that by 2015 the total world
industrial output in sectors likely to be influenced by
nanomaterials will be in excess of $10,000 Billion (Realis
http://www.inrealis.com). The same survey suggests that
by then about 10% of the output from the chemicals sec-
tor will be nano-influenced. The impact of nanotechnol-
ogy will be seen particularly by enabling innovation in the
areas of speciality and fine chemicals, and in materials for
pharmaceuticals and personal care products. Nanoparti-
cles and nanofibres will be particularly important in these
applications.
The unique size-dependent properties of nanomaterials
mean that in some ways they behave like new chemical
substances. For example, Nanoparticles can scatter and
absorb short-wavelength UV radiation but leave longer-
wavelength visible light virtually unaffected. This property
is exploited in transparent sunscreens. When fluorescent
Nanoparticles absorb UV radiation they emit visible light,
and the colour of the emitted light is different for Nano-
particles of different diameters. This effect is exploited
when Nanoparticles are designed as colour-coded fluores-
cent labels that can be attached to target molecules or used
as diagnostic markers. The changes in optical and trans-
port properties become very pronounced for Nanoparti-
cles smaller than about 30 nm. Particles in this range are
often called 'quantum dots' because size is then control-
ling the separation (or quantisation) of energy levels
inside the particle.
Some nanomaterials have been in volume production for
a very long time. Carbon blacks in the nanoparticles size
have been in production for more than a century, and are
used for manufacture of rubber products and pigments.
Fumed silica and other oxides such as titanium, alumina
and zirconium have been produced as nanomaterials for
over half a century and used as thixotropic agents in pig-
ments and cosmetics, and more recently as the basis for
fine polishing powders used in the microelectronics
industry. Much of this high volume production is based
on vapour phase flame or plasma reactions carried out
under highly controlled conditions.
New nanomaterials are now being developed for many
different applications, using new preparation techniques.
Volumes are low, often on a laboratory scale producing
<10 kg per day. Examples are magnetic materials for elec-
tric motors and generators as well as high density data
storage, high current electrode materials for fuel cells, bat-
teries and electrochromic displays, and materials with
new surface properties for paints, coatings for self-clean-
ing windows, stain-resistant textiles etc. These materials
are more expensive to produce than conventional materi-
als, and must therefore offer very high performance or
similar benefits to users to justify the additional cost. As
manufacturing costs fall with increasing volumes and the
maturing of nanotechnology methods, it can be predicted
that the advantages of nanomaterials will lead to steady
displacement of conventional materials in many high
value applications.
Surfaces and interfaces are very important for new nano-
materials. As particles become smaller, the proportion of
atoms found at the surface increases relative to the pro-
portion inside its volume. This means that Nanoparticles
can be more reactive, for example creating more effective
catalysts or more efficient filler materials that allow
weight reduction in composite materials. The higher sur-
face energy can also make Nanoparticles interact strongly
and stick together. If nanomaterial building blocks are
synthesised in such a way that parts of the surface are
sticky but other parts are passive and non-sticky, then ran-
dom Brownian motion in a fluid can cause the blocks to
stick together in defined ways to make larger structures.
This is the basis of so-called 'bottom-up' self-assembly
methods.
The chemicals industry is a key actor in exploiting nanote-
chnology because the nanomaterials that it produces are
the basis for product innovation across many industrial
sectors. The In Realis market survey highlights transporta-
tion equipment, electronic and electrical equipment,
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industrial machinery and instrumentation, rubber and
plastic products, metal industries, and printing and pub-
lishing as sectors where nanotechnology is expected to
have a large impact.
The study of materials such as ceramics, metals, colloids
and polymers has always involved science at the nanos-
cale, and it is in these areas that the introduction of nan-
otechnology as an engineering discipline will have the
earliest commercial impact. Advanced ceramics combine
well-controlled microstructures with complex composi-
tions and crystal structures. The use of nanoscale ceramic
powders of narrow size distribution and high purity will
allow compacting into ordered and uniform arrays, and
sintering at lower temperatures, to produce tightly-con-
trolled ceramic products for microelectronics, magnetic
recording, chemical applications etc.
Nanocomposites combine polymers with nanomaterials
to produce new thermoplastic and thermosetting materi-
als. The high surface area-to-weight ratio for nanomateri-
als, the high surface reactivity and the matching of scale
with polymer molecule dimensions can all contributes
towards improving composite properties. For example,
nanocomposites can have higher tensile strength or heat
distortion temperature than similar materials using con-
ventional fillers. These properties might be achieved with
lower loading of nanomaterial filler, reducing the weight
and increasing the transparency of nanocomposites com-
pared with conventional composites. The use of carbon
nanomaterials such as C60 fullerenes and nanotubes is a
particularly promising way of reinforcing composite
materials and perhaps making them lighter, stronger and
electrically and optically active at the same time.
1.3 Standards and terminology
It is widely accepted that there is an urgent need for stand-
ards in nanotechnology to support legislation and regula-
tion, risk analysis and communication, IP protection, and
methods for sampling and measurement. In October
2004 the Technical Board Working Group on Nanotech-
nologies of the European Committee for Standardisation
(CEN/BT/WG 166) launched a stakeholder consultation
involving questionnaires for industry and non-industry
groups.
The American National Standards Institute http://
www.ansi.org has formed a Nanotechnology Standards
Panel (ANSI-NSP), which issued a set of priority recom-
mendations. Four areas were deemed to be most urgent
for the next 12 months, and within each area 3 topics were
identified as having greatest importance. These groupings
of priorities for nanotechnology standardisation are:
Group 1: Systematic terminology for materials composi-
tion and features
• Composition
• Morphology
• Size
Group 2: General terminology for nanoscience and tech-
nology
• Definition of the term 'nano'
• Consideration of impact on intellectual property/other
issues
• Sensitivity to existing conventions
Group 3: Metrology/methods of analysis/standard test
methods
• Particle size and shape
• Particle number and distribution
• Particle mass
Group 4: Toxicity effects/environmental impact/risk
assessment
• Environmental health and safety
• Reference standards for testing and controls
• Testing methods for toxicity
Standards for the areas of 'Manufacturing and Processing'
and for 'Modelling and Simulation' were considered less
urgent (3–5 year timeframe).
As outlined in Group 4 above, the greatest current risk is
to the occupational health of workers involved in research
and manufacture of Nanoparticles and nanofibres. How-
ever, as applications of nanomaterials increase, the risk of
exposure to the general public will grow. It will be neces-
sary to monitor products that incorporate Nanoparticles
and nanofibres throughout their life, from manufacture to
disposal, in order to estimate the probability of environ-
mental emissions particularly from disposal and waste
management processes. Some products will involve direct
delivery of Nanoparticles to humans, for example injec-
tion of smart drug delivery systems and diagnostic mark-
ers and application of cosmetics to the skin. In some cases
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there could be unintentional uptake, for example inges-
tion of Nanoparticles used in food packaging technology.
The wide variety of routes by which Nanoparticles could
be taken up by the body complicates the definition of
Nanoparticles to be used in risk assessment and regula-
tion. It is probably necessary to consider multi-compo-
nent and multi-phase particles of any size and
composition that can be absorbed by the body and then
break up to deliver Nanoparticles or nanofibres to target
organs. Nanocoatings on implanted medical devices that
could shed Nanoparticles or nanofibres through use or
wear should also be included. The overall risk of exposure
to nanofibres may be lower than for Nanoparticles
because it appears to be more difficult to generate aerosols
of nanofibres.
1.4 Sources of nanoparticles
1.4.1. Unintentionally produced nanoparticles
Epidemiological studies consistently show that increases
in atmospheric particulate concentrations lead to short-
term increases in morbidity and mortality. Inhalation is
the most significant exposure route for those unintention-
ally- generated particles,. Regulation is aimed mainly at
particulate matter <10 μm in diameter (PM10) in the
atmosphere, but there is evidence that the adverse health
effects are greater for the fine particle fraction, defined as
having diameter <2.5 μm (PM2.5). Improvements in meas-
urement techniques have focused attention more recently
on ultrafine particles (UFPs), whose diameters < 0.1 μm
(PM0.1) is consistent with nanoparticles definitions. UFPs
dominate the number concentration of the ambient parti-
cle cloud, but represent only a small fraction of the total
mass concentration. The large number concentration of
UFPs existing in the atmosphere generates a background
against which emissions of manufactured Nanoparticles
and nanofibres will have to be measured and monitored.
The relative importance of different sources of atmos-
pheric UFP emission in the UK during 1996 was identified
in the report of the Airborne Particles Expert Group [8].
The major source of primary UFP was road transport
(60%), followed by combustion processes (23%, combin-
ing industrial, commercial, residential combustion and
energy production).
Particles in the atmosphere are defined as either primary
or secondary particles.
• Primary particles are emitted directly from sources or
processes, which might be natural (fires, volcanoes, sea
spray, erosion) or anthropogenic (traffic, industry).
• Secondary particles are formed in the atmosphere by
gas-to-particle conversions. Immediately following nucle-
ation the secondary particles are very small (~1–10 nm),
and grow by coagulation or condense onto existing sub-
micrometer particles. Homogenous nucleation, the for-
mation of very small particles may occur in hot
combustion gases and in metallurgical processes, includ-
ing welding.
1.4.2 Intentional production of nanoparticles
On the other hand, for decades industry has been inten-
tionally producing different kinds of manufactured Nan-
oparticles, for use in existing applications such as
pigments, resins and cosmetics. In addition, nanotechnol-
ogy will increasingly generate new materials and products
that are based on Nanoparticles, devices and tools. It is the
sum of existing and newly developed, intentionally pro-
duced (= manufactured) Nanoparticles that form the pri-
mary target of risk assessment in this review.
It may be that the emission of manufactured Nanoparti-
cles and nanofibres will add to the load of primary UFPs
in the atmosphere. The subsequent formation of agglom-
erates of Nanoparticles and fibres, or of multi-component
particulate matter containing adsorbed Nanoparticles,
will add to the load of atmospheric PM2.5 or PM10. The
formation of large complex particles incorporating nano-
scale components will need to be considered in the risk
assessment for nanotechnology because they create a
potential route for uptake of Nanoparticles and fibres. The
probability that emissions of manufactured Nanoparticles
might occur where there are already high concentrations
of UFPs in the atmosphere will require study to assess the
rates of interaction between the different types of particle,
and the likely products. Of course, the application of new
manufactured Nanoparticles and nanofibres in products
that are used directly by consumers means that other
routes of uptake for manufactured nanomaterials must be
considered in addition to inhalation, e.g. ingestion and
dermal absorption.
For most manufactured NP no toxicity data are available.
Most of the experimental, toxicological work on NP has
been generated with a small set of Nanoparticles, such as
carbon black (CB), titanium dioxide (TiO2), iron oxides
and amorphous silica. These NP have been manufactured
by the chemicals industry for some decades and are pro-
duced in many tons per year. These NP were considered to
be so-called nuisance dusts until it was observed that
upon prolonged exposure in rats, inflammation and lung
tumours can occur. The discussion on the risks of manu-
factured NP is mainly driven by epidemiological studies
that estimated that per 10 μg/m3 increase in the concen-
tration of environmental particles (PM2.5), overall mortal-
ity increases by 0.9%, while deaths from specific
respiratory diseases can increase by as much as 2.7% [9].
Experimental toxicological studies (with CB, TiO2) have
indicated that NP cause such adverse effects at lower dose
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levels than their fine counterparts, but so far few human
studies have been able to investigate this. In summary,
these findings set the stage for the current discussion on
risks of Nanoparticles illustrated as the scheme in Figure
1. The key-question is whether and how the different
pieces of toxicological and epidemiological evidence on
different NP can be mutually used or whether a more tar-
geted and systematic approach is necessary.
1.5 Production of manufactured nanoparticles
According to the National Nanotechnology Initiative
(USA), the largest production volume in 2004 was for
chemical-mechanical polisher (CMP) for semiconductor
wafers, for example ammonia-stabilized 40 nm colloidal
silica (sold under the name OX-200; no specific quantities
given). Thousands of tons of silica, alumina and ceria, in
the form of ultrafine abrasive particle mixtures that
include Nanoparticles, are used each year in slurries for
precision polishing of silicon wafers. Cabot Microelec-
tronics, the leading producer of CMP slurries, recently
announced that it has been working with Nano Products
Corporation for 2 years to develop specially engineered
Nanoparticles to improve the performance of next gener-
ation polishing products.
The manufacture of Fullerenes could soon match the engi-
neered metal oxide Nanoparticles in production quanti-
ties, with the Kitakyushu plant (Mitsubishi, Japan)
estimating an annual production of 1500 tonnes of C60 by
2007. Other manufacturing facilities also anticipate
increased production of fullerenes, and therefore the sum
production could be several thousands of tons of fuller-
enes by 2007. In 2003, Single-Walled and Multi-Walled
Nanotubes had a world-wide production of approxi-
mately 3000 kg (3 tonnes). However, the Carbon Nanote-
chnology Research Institute (Japan) plans on expanding
their production from ~ 1000 kg in 2003 to 120,000 kg
per year within the next five years. The worldwide produc-
tion capacity for single-wall and multi-wall carbon nano-
tubes is estimated to be about 100 tons in 2004 [10],
increasing to about 500 tons in 2008. Capacity for single-
wall nanotubes (SWNT) currently comprises less than
10% of the total, but is predicted to double as a propor-
tion of total capacity by 2008.
The likely global production for specially-engineered
nanomaterials is summarised in Table 1, using recently-
published data [10] based on review of chemistry journals
and market research:
The increase in production of engineered nanomaterials is
being fuelled by a worldwide growth in R&D, which is
seen as key to industrial innovation in many sectors. The
scale of investment in nano-related R&D is illustrated by
data taken from two recent publications, referenced in
Tables 1.2 and 1.3.
Although current production of engineered nanomateri-
als is small, it is evident that as a result of increased R&D
the rate of production will accelerate in the next few years.
Considering the tons of engineered nanomaterial planned
for production, it is likely that some of these materials will
enter the environment during the product's Life Cycle
(manufacture, use, disposal). In addition to these specifi-
cally engineered nanomaterials, it is estimated that
50,000 kg/year of nano-sized materials are being pro-
duced through these un-intended anthropogenic sources
such as diesel-exhaust and other combustion processes.
Given the large surface area to mass ratio of nano-sized
Illustration of the different sources and applications of ultrafine and Nanoparticles (NP)Figu e 1
Illustration of the different sources and applications of ultrafine and Nanoparticles (NP). Epidemiology and toxicology have 
demonstrated acute effects of anthropogenic NP (= UFP) in humans, as well chronic effects of existing, manufactured NP in 
animals. It remains an open issue whether the hazards and risks found with those types of NP can be extrapolated to newly 
developed engineered NP.
Unintentionally produced 
ultrafine particles (UFP), 
e.g:
-  Anthropogenic (diesel)
-  Natural (fires, nucleation)
Manufactured NP:
-  Existing NP (cf CB, TiO 2)
- Newly developed, engineered
   NP
Particle and Fibre Toxicology 2006, 3:11 http://www.particleandfibretoxicology.com/content/3/1/11
Page 7 of 35
(page number not for citation purposes)
materials, this is quite a large amount of reactive surface
area.
1.6 Roadmaps for future manufacture and applications of 
nanomaterials
There are two distinct approaches to making products
with nanoscale features and attributes.
Top-down fabrication is the method used in the microe-
lectronics industry, where small features are created on
large substrates by repeated pattern transfer steps involv-
ing lithographic methods. Extreme UV photolithography
can produce patterns with feature sizes down to 100 nm,
and electron beam lithography can be used for features
down to 30 nm.
Bottom-up fabrication is directly relevant to the chemi-
cals industry. This method starts with very small units,
often individual molecules or even atoms, and assembles
these building-block units into larger structures – clearly
the domain of chemistry. What nanotechnology brings is
the idea that the assembly can be hierarchical and control-
led in specific ways. Some recent reports give a vision of
how manufacture and applications of nanomaterials
could evolve in the next 10–20 years:
'Nanomaterials by Design' [12]
This report was prepared by a working group representing
the US chemical industry. It proposes actions that by 2020
will enable the industry to offer a library of nanomaterial
building blocks with well-characterised compositions, sta-
ble architectures and predicted properties. There will be
safe, reproducible and cost-effective 'bottom-up' manu-
facturing and assembly methods to incorporate these
nanomaterial building blocks into devices and systems
designed to perform specific functions whilst retaining the
nanoscale attributes.
'Vision 2020 – nanoelectronics at the centre of change' [13]
This report was prepared by representatives of European
industrial and research organisations as a roadmap for
development of microelectronics in Europe. Break-
through applications enabled by nanomaterials could
include new data storage devices, flexible displays, molec-
ular transistors and novel sensor and actuator devices.
'Nanotechnology – innovation for tomorrow's world' [14]
The German Association of Engineers- Technology Centre
(VDI-TZ) for the German government prepared this
report. It describes the scientific background to nanotech-
nology developments and future areas of application. It
contains many illustrations of how everyday objects and
activities will be affected by the use of nanomaterials, and
how this could change people's lives for the better.
2) Physico-chemical and surface properties of 
nanoparticles: aggregation and disaggregation
2.1 Properties of nanoparticles
Nanoparticles are unique since between 1 and 100 nm the
physical behaviour of particles changes from classical
physics to quantum physics with decreasing particle size.
A nanoparticle with a radius of 2.5 nm and a density of 5
g/cm3 has a surface of 240 m2/g when assuming a ball like
shape. That means that around 20% of the particle atoms
are at its surface. However, the surface of a nanoparticle is
never "naked". Due to high energetic adhesive forces close
to the surface, the particles are either agglomerated to
their neighbours, glued to the next available surface or
Table 1: Estimated global production for engineered nanomaterials[11]
Application Nanomaterial/device Estimated global production (tonnes per year)
2003/04 2010 2020
Structural applications Ceramics, catalysts, films & 
coatings, composites, 
metals
10 103 104 – 105
Skincare products Metal oxides (eg. TiO2, 
ZnO)
103 103 103
Information & 
Communication 
Technologies
SWNT, nanoelectronic and 
optoelectronic materials 
(excluding CMP slurries), 
organic light emitters and 
electronics, 
nanophosphors
10 102 >103
Biotechnology Nanocomposites & 
encapsulates, targeted drug 
delivery, diagnostic 
markers, biosensors
<1 1 10
Environmental Nanofiltration, membranes 10 102 103 – 104
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work like an activated charcoal filter towards other small
molecules. Varying its composition, size or surface com-
position can therefore change the physical and chemical
properties of a nanoparticle:
• Size effects: Depending on the material used to produce
Nanoparticles, properties like solubility, transparency,
colour, absorption or emission wavelength, conductivity,
melting point and catalytic behaviour are changed only by
varying the particle size.
• Composition effects: it is clear that different particle
compositions lead to a different physical and chemical
behaviour of the material.
• Surface effects: Properties like dispersibility, conductiv-
ity, catalytic behaviour and optical properties alter with
different surface properties of the particle.
When it comes to the technical application of synthetic
Nanoparticles, all those parameters need to be controlled.
However, if the surface properties cannot be controlled,
Nanoparticles quickly turn into larger particles due to
agglomeration. Most of the size dependent effects are then
lost. On the other hand biological adverse effects seem to
be driven by the same exceptional effects of NP, that is
large and active surface area [15,16]. The discussion
whether single particles or agglomerates are important in
these effects has not been resolved yet, but nanotubes
ingested by macrophages were reported to be present as
single particles based on their chemical properties [17].
This chapter will mainly deal with single and agglomer-
ated particles from the point of view of synthesis and
application. When it comes to the application of new
properties of nanomaterials, synthesising Nanoparticles is
not enough. It is their dispersion in the product that mat-
ters and makes Nanoparticles so attractive. When agglom-
erated, Nanoparticles loose those properties that are
determined by size like colour and transparency. Since
agglomerates tend to settle out they are difficult to be dis-
persed within a polymer matrix, an ink, paint, cream etc.
For the application of Nanoparticles, it is therefore crucial
to control their agglomeration behaviour. Dispersed Nan-
oparticles are needed in order to retain their specific prop-
erties for the technological applications (fig 2).
2.2 Synthesis of nanoparticles and their aggregation
From an application point of view dispersed Nanoparti-
cles are ideal. Whether or not Nanoparticles can be dis-
persed or not strongly depends on the synthetic route
chosen to produce it.
- Milling: Milling materials down to the nanometre
regime belongs to the so-called top-down approach.
Macro material is filled into a ball mill or something sim-
ilar and can be milled down as far as around 30 nm. The
advantage is the low cost of the procedure. One disadvan-
tage is, that the grain boundaries are still touching and
stick strongly together. Thus these particles are very diffi-
cult to disperse. Additionally high mechanical forces
applied to the material can lead to a disruption of the lat-
tice of the particles and which could dramatically change
its properties.
- Gas-Phase: Gas-Phase procedures belong to the so-called
bottom-up approach. Precursors of the end product are
being reacted in the gas phase in a vacuum chamber and
crystal growth is controlled by parameters like precursors,
temperature and concentration. Anticipated advantages
include high quality particles, mass produced fairly
cheaply and with a highly defined particle size distribu-
tion. The main disadvantage is difficulty in controlling the
surface of the Nanoparticles.
- Wet-Phase: The wet-phase procedure also belongs to the
bottom-up approach and works only in solution. Mole-
cules in the reaction mixture, temperature and reaction
time control the crystal growth. The advantage of this pro-
cedure is the total surface control during every stage of the
particle growth. Disadvantage is mostly price and scalabil-
ity of the process. Mostly liquid phase synthesis leads to a
dispersion of Nanoparticles. Since the solvent is either
hydrophilic or hydrophobic, the application of such dis-
persion is limited. Latest developments however show
that Nanoparticles agglomerated on purpose can be floc-
culated out of the liquid phase or stay perfectly dispersible
in a solvent. Starting from a dispersible powder the surface
composition can be chemically changed and adjusted to
many different solvents and applications.
2.3 Synthesis of nanoparticles and their aggregation
Generally, most suppliers apply a post- synthetic strategy
to modify Nanoparticles to prevent aggregation or stimu-
late disaggregation. Therefore particle powders are
mechanically milled under the addition of dispersing
additives. The additives form a layer around the particle
and inhibit aggregation. If the synthetic route allows the
introduction of surface molecules before agglomeration
takes place, particles can be dispersible in certain media
straight away. Additionally surface molecules can be
changed by chemical synthesis after the particle has
formed. This post synthetic route opens a variety of possi-
ble surface modifications, which can be adjusted to any
application. In some cases especially in water, particles
can be stabilized by their surface charge. This behaviour is
influenced by the ion content of the water and the
amount of charged ions on the surface of the particle.
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There is a body of evidence from drug delivery and toxico-
logical literature that surface modification as well as sur-
face charge can have major impact on biological response
to particles, including phagocytosis, genotoxicity, and
inflammation. Coating of particles with polyethylene gly-
col is a common treatment in drug delivery to prevent rec-
ognition by the reticulo-endothelial system (Chapter 4)
and increase the half-life of the particle conjugated drugs.
Surface modified TiO2 has been the subject of considera-
ble investigation which has shown that the hydrophobic
coatings usually tend to lower the inflammatory response
after inhalation or instillation [18,19]. Therefore, it is rec-
ommended that the surface modification and the agents
used are vital information in the description of any nano-
particle.
2.4 How to assess the surface properties of nanoparticles
As discussed above the technical application of Nanopar-
ticles mainly depend on their surface. It is therefore crucial
to the chemist to control the surface and thus the proper-
ties of single particles. However, the qualitative and quan-
titative analysis of the surface of a single nanoparticle or a
nanoparticle ensemble is challenging. The following
methods are commonly used.
2.4.1 Zeta potential
The zeta potential is a function of the surface charge of the
particle or any adsorbed layer at the interface and the
nature and composition of the surrounding medium in
which the particle is suspended. It is usually of the same
sign as the potential at the particle surface. The zeta poten-
tial is readily measurable by experiment. It reflects the
effective charge on the particles and is therefore related to
the electrostatic repulsion. The zeta potential is a relevant
tool for the practical study and control of nanoparticulate
dispersions. The Zeta potential however, gives no infor-
mation on the chemical composition, or the elemental
composition of the surface.
2.4.2 Secondary ion mass spectroscopy (SIMS)
SIMS is a destructive method that gains information about
the atomic compositions of layers from 1–3 nm with a
high lateral resolution. SIMS and other similar methods
however, can only give information about the elemental
Dispersed Nanoparticles are needed in order to retain their specific properties for the technological applicationsFigure 2
Dispersed Nanoparticles are needed in order to retain their specific properties for the technological applications.
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composition of a material and say nothing about the
chemical properties like reactivity and binding states of
the elements near the surface.
2.4.3 X-ray photoelectron spectroscopy (ESCA)
Electron spectroscopy for chemical analysis (ESCA) is a
non-destructive method used to measure the atomic com-
position of layers between 1–10 nm with a rather poor lat-
eral resolution. It therefore is an excellent method to
characterize the chemical composition of nanomaterials.
ESCA gives information not just about the elemental com-
position of a material but also about the binding state of
different elements. It is a sensitive method to measure the
distribution of different elements down to 1 atom%.
2.4.4 Thermogravimetry
In thermogravimetry, surface molecules are removed from
a nanomaterial by slowly heating the material and meas-
uring the change in weight. In addition mass spectroscopy
can be used online to measure the type of molecule
removed from the surface. In combination, both methods
give a good picture of the molecules bound to the surface
of a nanoparticle.
2.4.5 Atomic force microscopy (AFM) and scanning tunnelling 
microscopy (STM)
AFM and STM are based on the use of a fine needle scan-
ning over a given surface. This can be controlled even
below atomic resolution. Thus they are powerful methods
not only to measure structures and topographies of nano-
materials but also, in combination with chemical force
microscopy, to identify single molecules on surfaces. The
information about a single particle its chemistry, charge,
magnetic properties etc. can be very high, provided that
the particle can be fixed. The information about an
ensemble of particles however, is poor.
2.4.6. Particle surface reactivity
Rapid approaches that have been used to determine parti-
cle surface reactivity fro toxicology studies include e.g.
testing of plasmid DNA unwinding or oxidation of calf
thymus DNA [20,21]. Electron paramagnetic resonance
(EPR) combined with a spin-trap has been used to deter-
mine the radical generation properties of particulate
materials well above the nanosize range such as quartz
and asbestos in relation to (surface) modification as well
as of ambient particulate matter. In general, these EPR
studies showed positive associations with toxicity in vitro
and/or in vivo toxicity [22-24]. Nanoparticles such as
fullerenes are well known to produce such reactive oxygen
species in suspension [25,26] and these properties are
considered relevant for both technological application
and toxicological hazard.
3) Exposure potential during ongoing production 
and application: role of processes
3.1 Introduction
This chapter is related to the health and environmental
safety of Nanomaterials. Therefore any discussion related
to "combustion" Nanoparticles, such as diesel soot are
not included. More specifically, the discussion is focussed
on manufactured nanoparticles (NP) and their agglomer-
ates being produced for direct or indirect commercial and/
or industrial use. Agglomerates of NP can be larger than
100 nm in diameter but have to be included in the discus-
sion since they may break down on weak mechanical
forces or in solvents. No differentiation between agglom-
erates and aggregates is made here since no clear defini-
tion to distinguish those two exists.
The differentiation coming from engineering science is
important for the risk assessment of NPs. Studies related
to and a definition based on the stability of agglomerates
during uptake by humans is important since it changes
the active number and surface concentration and hence
influences the dose response. The US EPA poses six pri-
mary questions that the exposure assessment should
answer:
1. How does exposure occur?
2. What or who is exposed?
3. How much exposure occurs? When and where does it
occur?
4. How does exposure vary?
5. How uncertain are exposure estimates?
6. What is the likelihood that exposure will occur?
A general systematic approach is introduced in paragraph
3.2, while paragraph 3.3 deals with the questions 1, 3, 6.
Paragraph 3.4 gives a summary of the available instru-
mentations and method recommendation for NP expo-
sure measurements, while 3.5 discusses questions 2, 4 and
5.
3.2 Process/product lines of nanoparticles and possible 
exposure
Figure 3 shows a general scheme on the production of NP.
The boxes indicate different steps in the production, treat-
ment and processing of NP. Within the boxes small, green
boxes are included to denote closed cycles with no inten-
tional release of product/by-product NP. Generally,
release of NP can occur in closed cycles through e.g. leaks
and during the transfer of the intermediate or final prod-
uct to other handling steps. This exposure to NP is mainly
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related to workers since all these steps take place in work-
ing environments as indicated by the dashed line. Expo-
sure of the public to NP can only occur through the
product or release of NP's to the environment through
stack or diffusive emissions.
Conclusions and recommendations:
- No systematic approach related to the control of NP-pro-
duction and -products exists to our knowledge.
- Therefore the above or a similar scheme should be
implemented for exposure and hence risk assessments for
NP processes, treatment and products.
- Other recommendations related hereto are the expert
recommendations 1 and 2 in Nanotechnologies [27],
including Development of a nomenclature for intermedi-
ate and finished engineered nanomaterials as an interna-
tional effort (expert recommendation 1) and Assignment
of a universally recognized Chemical Abstract Service
(CAS) Number to engineered NPs (expert recommenda-
tion 2).
- Sources of NPs not directly related to Nanomaterials or
its production should be separated from the discussion as
indicated in the expert recommendations 1 and 2 above.
Still, they have to and will be included in the discussion
of health effects induced by Nanoparticles.
Scheme of NP production and possible exposureFigure 3
Scheme of NP production and possible exposure.
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3.3 Exposure potential to NP
Separate factors have to be investigated and discussed to
assess the exposure potential. Rephrasing the questions
given in the introduction the following relevant factors are
identified:
- Probability of exposure
- Extent of exposure (time and concentration)
- Uptake route (inhalation, trans-dermal, ingestion)
No systematic approach is currently available assessing
the probability of exposure related to NP production and
handling processes. A systematic assessment of this could
be based on the scheme presented in paragraph 3.2. Dif-
ferentiation can be made e.g. between closed production
cycles and "open" handling of the products/by-products.
A systematic review on applied production methods,
products and their handling must be compiled before any
specific recommendations can be given related to the
probability of exposure. Post-synthetic processing to
achieve particle dispersion and surface-modifications (as
described in Chapter 2) also need to be included in such
a review.
Uptake of Nanoparticles by humans may occur by inhala-
tion, trans-dermal or by ingestion. The currently mostly
discussed and investigated exposure route is via inhala-
tion. This route has to be treated differently to trans-der-
mal processes and ingestion. It is difficult tp assess the
personal exposure to NP and ultrafine particles. No per-
sonal sampler exists to specifically measure the concentra-
tion (either mass or number concentration) of particles
below 100 nm diameter. Current standard occupational
exposure measurements are based on mass concentra-
tions of the inhalable or alveolar particle size fraction.
First measurements of number size distributions of parti-
cles at working places to assess the potential exposure
were conducted at a few selected working places/areas.
The exposure can currently be only deduced/calculated
based on the limited measurements conducted so far.
Recommendations are:
- Develop a systematic review of applied and planned NP
production methods, products and their handling.
- Develop a systematic approach in assessing the release
potential related to NPs and their agglomerates.
- Develop a method to reproducibly assess personal expo-
sure to NP and their agglomerates.
- Compile current data on number size distribution meas-
urements in working areas and estimate personal expo-
sure levels to derive an overview on possible exposure
levels.
- Measure/Calculate exposure of the skin to Nanomateri-
als and especially NP for workers handling powder like
Nanomaterials such as Carbon Black or Titanium dioxide.
- Development and promotion of good practices in han-
dling Nanomaterials (see also expert recommendation 6
in BIA report on "ultrafine particles at working places
http://www.hvbg.de/d/pages/index.html.
3.4 Methods for characterization and assessments of 
exposure
3.4.1 Which metric to use for NP exposure?
One of the key questions related to Nanomaterial expo-
sure is the particle parameter to be measured. Possible
parameters could be number concentration, surface area,
mass concentrations, weighted size distribution, state of
agglomeration, surface reactivity (e.g. ability to produce
radicals, zeta potential), chemical composition, and mor-
phology.
Due to the vast number of characteristics, which can be
determined for Nanoparticles only a brief overview of
measurement methods can be given. A technical report on
"Occupational Ultrafine Aerosol Exposure Characteriza-
tion and Assessment http://www.hvbg.de/d/pages/
index.html is currently drafted and includes an extended
review on particle characterization methods. It has to be
noted that mass concentrations of ultrafine particles are
generally extremely low and hence cannot easily be deter-
mined in current standard exposure measurements.
Number concentrations, in contrast, are mainly domi-
nated by particles in the ultrafine size range. Since the lat-
ter can be determined relatively easily by e.g.
condensation nucleus counters. This is the main parame-
ter currently used in exposure measurements.
Figure 4 provides a schematic example how particle meas-
urements can be done in relation to exposure assessment.
This scheme clearly indicates the possible approaches to
exposure measurements related to Nanomaterials. A thor-
ough review of available techniques and evaluation of this
with the toxicological community will be an important
tool to outline the future directions in R&D. This should
be done with an international expert group.Exposure
assessments to NP and their agglomerates can only be
done currently by room/area measurements since per-
sonal samplers specifically for NP do not exist. Therefore
systematic and harmonised measurement strategies must
be developed and employed taking into account the spe-
cial variability on concentrations. Specific care has to be
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taken in the identification of sources since sources like
nearby traffic may significantly influence the concentra-
tions without being related to industrial Nanomaterials.
Topics generally to be harmonized are:
- Measurements techniques for physical and chemical
characterization (including speciation if toxicological rel-
evant e.g. of NP and of their agglomerates).
- Measurement parameters for standard not explorative
exposure measurements
- Measurement strategies, including area screening and
background influences.
Recommendations are:
- International agreement on particle parameter(s) to be
determined in occupational exposure.
- Use of novel or currently not used particle measurement
techniques in exposure measurements such as particle
reactivity (e.g. ESR measurements) along with epidemio-
logical studies.
- Development of personal samplers to determine per-
sonal exposure to NP and their agglomerates (number
and surface concentration measurements may be possible
in the near future).
- Development of a model describing the dispersion and
transformation of NP and their agglomerates in the work-
ing environment to a) assess location of maximum expo-
sure and b) to develop/plan safe working environments.
- Development of standard measurement methods and
strategies to harmonize exposure data for risk assessment
and to enable the development of safety standards.
- Standardisation of number concentration measurements
including definition of the lower and upper particle size
range determined and defined relative humidity.
3.5 Different product lines in view of exposure
NP currently produced in large mass quantities globally
include Titanium, Silica, Alumina, Metals and Carbon.
Other NPs currently used are include carbon nanotubes
and Barium sulfate. Only few studies systematically
approaching exposure to NP and their agglomerates exist.
A further handicap is that the reports of these studies are
often not available for the public. Examples of these stud-
ies are given in e.g. Proceedings of the International Sym-
posium "Dusts, fumes and mists in the workplace" [28].
Some limited measurements of particle size distributions
and number concentrations were conducted. Kuhlbusch
et al. [29] determined number size distributions and mass
concentrations in various working environments at sev-
eral carbon black production plants.
These are just examples, but a much more systematic and
comprehensive approach is necessary to derive a good
overview of exposure to industrial Nanomaterial and
especially Nanoparticles.
Recommendations are:
- Development of a systematic categorization system for
Nanomaterials based on physical-chemical information
of the Nanomaterial and related to toxicological screening
methods.
Scheme of particle characterization for exposure assessmentFigure 4
Scheme of particle characterization for exposure assessment.
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Systematic compilation of Nanomaterial production
processes, handling and products for the assessment of
the current knowledge and identification of processes and
products with lack of information (may be internally to
include non-public studies).
4. Toxicology of nanoparticles
4.1 Evidence for nanoparticles in ambient particle effects
The largest database on the toxicity of Nanoparticles has
originated from the PM10 literature, where the 'NP
hypothesis' has proved to be a powerful force for research.
Therefore we consider it relevant to discuss this evidence
in the expectation that it will shed light on the toxicity of
engineered NP. The idea that combustion-derived Nano-
particles (NP) are an important component that drives the
adverse effects of environmental particulate air pollution
or PM10 comes from several sources [30]:
1) Much of the mass of PM10 is considered to be non-toxic
and so there has arisen the idea that there is a compo-
nent(s) of PM10 that actually drives the pro-inflammatory
effects and combustion-derived NP seems a likely candi-
date.
2) NP are the dominant particle type by number suggest-
ing that they may be important and their small size means
that they have a large surface area per unit mass. Particle
toxicology suggests that, for toxic particles generally, more
particle surface equals more toxicity.
3) Substantial toxicological data and limited data from
epidemiological sources support the contention that NP
in PM10 are important drivers of adverse effects.
4.1.1. What effects of PM10?
The adverse health effects of PM are measurable as exacer-
bations of respiratory disease and deaths as well as hospi-
talisations and deaths from respiratory and cardiovascular
disease [31]. Inflammation is the common factor that
binds together these adverse effects and the ability of NP
to cause inflammation can be seen as an important prop-
erty and this is addressed fully below. It is not clear what
effects of PM10 have pulmonary inflammation as a pre-
requisite and what effects could potentially be driven by
exposures at levels below those causing inflammation.
There is also the potential for pulmonary inflammation to
results in changes in membrane permeability that in turn
may impact the potential for particles to distribute
beyond the lung. In addition, some NP are known to be
able to redistribute from their portal of entry e.g. intersti-
tialise in the lungs [32] and enter the brain [33] and the
blood [34] (see 4.2). Therefore some NP may have the
extra potential of affecting cardiovascular disease directly.
However, data to date are limited and not all studies of
Nanoparticles have shown significant translocationfrom
lung to the blood. Understanding the particle characteris-
tics (size, charge, lipophilicity, protein adsorption) that
impact the translocation process and the potential for
dose rate effects on translocation will be important both
in terms of dose rate effects on competing clearance mech-
anisms (mucociliary) and potentially on barrier function.
Beyond that, understanding clearance kinetics of Nano-
particles will also be important in understanding their
potential for adverse effects. Therefore NP have the poten-
tial of affecting cardiovascular disease both indirectly via
pulmonary inflammation and directly through particle
distribution although important, this property of redistri-
bution has yet to be demonstrated for NP present in real
PM10. Of note, many of the effects attributed to exposure
to high levels of ambient particulates are also present in
patients with chronic obstructive pulmonary diseases
(COPD) (presumably independent of ambient particle
exposure status). COPD and other disorders associated
with reduced lung function are strong risk factors for car-
diovascular events, independent of smoking. While the
mechanism(s) for this observation is/are largely
unknown, there is evidence that suggests that low-grade,
systemic inflammation related to COPD may play an
important role. In a severity-dependent fashion, circulat-
ing levels of C-reactive protein, fibrinogen, and other
inflammatory biomarkers are 1.5 – 3.0 times higher
among individuals with COPD than in those without [35]
Importantly, COPD patients with elevated C-reactive pro-
tein and other inflammatory biomarkers have a higher
risk of cardiac events than those with normal C-reactive
protein levels. The risk of cardiovascular events may be
further amplified by the use of bronchodilators that
adversely alter the delicate balance of sympathetic and
parasympathetic forces within the autonomic nervous sys-
tem. In sum, COPD is a risk factor for cardiovascular dis-
eases. Persistent systemic inflammation may, in part, be
responsible for this relationship. It is important to keep in
mind that the effects of ambient air pollution involve a
complex interplay between the complex constituents of
the ambient particles and underlying disease. However, it
is clearly appropriate to include endpoints reflective of
ambient particulate exposure in studies of the effects of
engineered Nanoparticles to understand the potential for
different types of particles to elicit these effects and the rel-
ative dose/response.
4.1.2. Characteristics of NP in PM10
NP in PM10 are mainly produced as a by-product of com-
bustion and in conurbations predominantly emanate
from traffic vehicles. It is possible that manufactured Nan-
oparticles such as NP carbon black or NP titanium dioxide
are locally important, near industrial facilities or dumps,
but this is likely to be the exception. Fly ash from the
burning of pulverised coal contains a NP fraction [36] and
so point sources of this NP may impact on PM10 effects
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locally. Even though combustion of coal and oil also pro-
duces NP-sized particles [36,37], in most urban situa-
tions, where most exposure occurs, it is the vehicle
emission that contributes the majority of the NP [37]. In
addition, it needs to be mentioned that secondary UFP do
contribute to ambient UFP exposure [38] and that the sol-
ubility of these UFP is greater than for primary combus-
tion derived UFP.
In most cases UFP do not occur as single particles but as
aggregates of smaller particles. Both diesel and gasoline
combustion results in the production of an aerosol that is
nanoparticle in primary particle size [39-41]. Kubo et al
[42] identified two peaks of Nanoparticles in diesel
exhaust – a 30 nm (nuclei) mode comprising volatile spe-
cies that can be defined as nanodroplets and an 80 nm
nanoparticle (accumulation) mode with a solid carbon
core. The primary particles can rapidly form aggregates
[40,41] and the nanodroplets may volatilise over time
and so neither be directly measured as NP by a size-selec-
tive sampler. The nanodroplets of organic material have
an extremely complex chemical composition, comprising
C13-C35 hydrocarbons (e.g. aldehydes, ketones and alkyl
nitrates), PAHs (e.g. benzo(a)pyrene) and nitro-PAHs
(e.g. nitropyrene) [41]. The nanodroplets are formed
largely from branched alkanes and alkyl-substituted
cycloalkanes from unburned fuel and lubricating oil [43],
plus a few percent sulphuric acid [44]. Background levels
of NP in the outdoor environment are in the range 5000–
10,000 particles per cm3 rising, during pollution episodes,
to 3,000,000 particles/cm3 [45]. However NP readily
aggregate into larger size classes [46], and these aggregates
may not be detected as NP but it is known that aggregates
retain the toxicity of the NP that comprise them (see
4.1.3). NP are also readily measurable indoors and since
we spend more than 90% of our time indoors then the
indoor environment can be important and it is notable
that vacuum cleaning and cooking have been reported to
dramatically increase airborne NP numbers [47,48].
4.1.3. Epidemiological evidence of a role for NP in the adverse effects 
of PM10
There is only indirect epidemiological evidence that com-
bustion NP are a factor in PM10 that drives the adverse
health effects. More data are likely to be available soon as
up to this point there have been few long-term measure-
ment campaigns that measured NPs. Most epidemiologi-
cal studies cannot discriminate whether effects are due to
NP or not as 1) they do not measure the NP; 2) NP in
aggregates or adhered to larger particles may be registered
by a sampler as larger-than-NP in size. However we know
from controlled toxicological studies that aggregates
retain the essential extra toxicity of NP; aggregates do not
behave like a geometric particle the size of the aggregate
because the greater surface area of the individual particles
is retained in the aggregate and is involved in toxicity.
Peters et al showed a correlation between the number of
ultrafine particles (NP) and decreases in evening peak
flow in a panel of 27 non-smoking asthmatics [49]. May-
nard and Maynard [50] used a historical approach and
reinterpreted exposure data on the London smogs. They
recalculated exposure as surface area, a manoeuvre that
takes particle size into account and emphasises the role of
combustion-derived NP surfaces and particle number.
Much of the London smog particulate in historic lungs
can be seen to be NP and generally supports the 'ultrafine'
or NP hypothesis [51]. The recalculation of Maynard and
Maynard showed that surface area was a better indicator
of heath effects associated with exposure to PM. Such a
finding supports the contention that NP are important
because they have such a high surface area per unit mass
compared to bigger particles. Peters et al demonstrated
two different time-response correlations between PM lev-
els and myocardial infarction- one at 2 hours and one at
24 hours [52]. NP have been reported to rapidly intersti-
tialise and become bloodborne following instillation [34]
and inhalation [53], although translocation to blood and
tissues in the latter study was only minor. A direct effect of
bloodborne particles on atheromatous plaques could
explain the 2 hour relationship reported by Peters [54]
whilst a more slowly developing inflammatory response
affecting plaques could explain the 24 hour effect. These
are, of course speculative conclusions based only on cor-
relations.
4.1.4. Toxicological data supporting a role for NP in the adverse 
effects of PM10
It should be noted that there are several mechanisms
whereby NP could lead to inflammatory effects, as is the
case for larger particles. These mechanisms could be based
on the large surface area of particle core or on soluble
components released by the NP. Several toxicological
studies support the contention that NP in PM10 could
drive inflammatory effects. There are a number of compo-
nents of PM10 that contribute to the mass but have little
toxicity – these include salts such as sulphates, chlorides
and ammonium salts and nitrates, but also wind-blown
or crustal dust. In fact within PM10 there are only few com-
ponents that toxicologists would identify as likely media-
tors of adverse effects – i.e. particle surfaces, organics,
metals and endotoxin (in some PM samples). In fact, a
large surface area, organics and metals are all characteristic
of combustion-derived particles [55] and so these have
attracted considerable toxicological attention [56],
[57,58]. Diesel exhaust particles (DEP) cause inflamma-
tion in the lungs in subjects exposed to it for a few hours
[59,60] and in animals [61] and causes pro-inflammatory
effects in cells in culture [62]. It is difficult to untangle, in
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a combustion particle sample, the relative roles of surface,
organics and metals, although this has been most
attempted in vitro (see below).
4.1.5. NP surfaces
Combustion nanoparticles with very low organic and
metal content- e.g.NP carbon black – have been investi-
gated and have been shown to cause inflammation via
their surface characteristics and not by any soluble mate-
rial [63]. In support of this, a wide variety of low toxicity,
low solubility particle types, not all combustion derived,
were shown to induce inflammation in direct relation to
their surface area [16]. From this it is clear that a high sur-
face area of particles in the lung is sufficient to initiate
inflammation.
4.1.6. NP-associated organics
Organic chemicals associated with NP play a role in the
pro-inflammatory effects of diesel exhaust particles, as
demonstrated in a number of in vitro studies. However it
should be noted that the types of studies described below,
where done with organics extracted from diesel or carbon
black particles and then used on cells. Those studies do
not take into account bioavailability from these organics
in particles, and often result in doses of organics that are
enormous compared to what could anticipated from a
plausible diesel particle exposure [64].
DEP caused modest stimulation of different cytokines and
growth factors, including interleukin-8 (IL-8), granulocyte
macrophage colony-stimulating factor (GM-CSF) by epi-
thelial cells and this activity was lost upon extraction of
the organic matter [65]; the benzene extracts were found
to contain most of the stimulatory activity seen in the
whole DEP. Benzene extracts contained almost 90% of the
B(a)P content and the authors concluded that PAHs such
as B(a)P were likely responsible for the stimulation of
cytokine production by the epithelial cells. Boland et al
[66] demonstrated that DEPs stimulated IL-8, GM-CSF,
and IL-1β release from the bronchial epithelial cell-line
16HBE. Furthermore they contended that this was related
to the amount of adsorbed organic compounds, because,
in comparison carbon black with virtually no adsorbed
organic matter, did not cause cytokine release. In support
of this the exhaust gas post-treatments, which diminished
the adsorbed organic compounds, also reduced the DEP-
induced increase in GM-CSF release. Further studies with
the organic extracts confirmed that most of the stimula-
tory activity seen in the DEP sample was in the organic
fraction [67]. In another study PAH extracted from DEP
induced expression of IL-8 and RANTES in peripheral
blood mononuclear cells [68], demonstrating that both
macrophages and epithelial cells could be important in
the pro-inflammatory effect induced by DEP in the lungs.
Chin et al [69] demonstrated that carbon black-treatment
of the RAW264.7 mouse macrophage cell line had no
effect on TNFα release but that the addition of BaP to the
particles caused them to become stimulatory for TNFα.
4.1.7 NP-associated metals
Metals have been reported to be involved in the oxidative
stress produced by diesel soot [70] and transition metals
have been reported to be involved in the redox cycling of
quinones, a major organic species considered to be
involved in oxidative stress caused by ambient particles
[71,72]. Experimentally, transition metals and NP sur-
faces act synergistically in producing inflammation [73],
and the final common pathway of oxidative stress medi-
ated cytokine gene transcription seems the likely explana-
tion [74].
4.1 Summary
It is generally considered that PM10 mass is not the true
driver of the adverse effects of particulate air pollution and
toxicological considerations of the components suggest
that one or more components in fact drives these effects
and that PM10 mass is really a surrogate. There is both
direct and indirect evidence that combustion-derived NP
is one important component that could be a key exposure
in the adverse effects of PM10. Three important pro-
inflammatory factors are associated with combustion-
derived NP including high particle surface area, organics
and metals (Figure 4.1). This 'nanoparticle hypothesis'
needs to be further tested in epidemiological and toxico-
logical scenarios. It remains to be investigated whether
and how relevant these reports of adverse effects of envi-
ronmental combustion-derived NP are for engineered
Nanoparticles, which may dramatically differ from them
in physical and chemical characteristics.
4.2. Distribution and kinetics of nanoparticles in the body
4.2.1. Deposition in the respiratory tract
Nanoparticle deposition in the respiratory tract is deter-
mined predominantly by diffusional motion due to ther-
mal motion of air molecules distorting particles from
their stream lines of the inhaled and exhaled air towards
the walls where they deposit. Diffusional motion is affect-
ing particle deposition through three important compo-
nents (aerosol properties and physiology) during
breathing:
(a) particle dynamics including the size and shape and its
possible dynamic change during breathing;
(b) geometry of the branching airways and the alveolar
structures; and
(c) breathing pattern determining the airflow velocity and
the residence time in the respiratory tract and including
nose versus mouth breathing.
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Regarding regional particle deposition the respiratory
tract acts as a series of filters starting with the nose or
mouth, via the various diameters of airways to the alveoli.
Fig 6 displays that particles of different sizes deposit dif-
ferently in the airways, as well as the alveolar region. The
smaller the particle, the higher the probability that a par-
ticle will hit the epithelium of a lung structure. The depo-
sition increases in all regions of the lung with decreasing
particle diameter below 500 nm due to the increasing dif-
fusion mobility. This means that Nanoparticles of differ-
ent sizes can have different effects in different parts of the
lungs. This may be particularly important in children with
developing lungs and in asthma and COPD patients.
These diseases may also cause increased deposition of PM
in diseased parts of the lungs up to several fold, which
may deteriorate their functions.
4.2.2 Fate of particles in the lungs
On the walls (epithelium) of the respiratory tract particles
contact first the mucous or serous lining fluid and its sur-
factant layer on top. Therefore, the fate of particle com-
pounds soluble in this lining fluid need to be
distinguished from slowly dissolving or even insoluble
compounds.
Slowly dissolving and insoluble NP deposited on the airway
wall will only be partly moved by action of ciliated cells
with the mucus or by cough within 1–2 days to the throat
(larynx), where they are swallowed. The smaller NP are
the more they are retained in and beyond the airway epi-
thelium.
Slowly dissolving and insoluble NP deposited in the alveolar
region will only be taken up and digested to a limited
amount by specialised defence cells that are called macro-
phages and are located in the alveoli. Therefore, alveolar
macrophages will determine the fate of this rather small
fraction of NP. The remaining NP will interact with the
cells of the epithelium such that NP will be taken up by
those cells or transported into the interstitial spaces. As a
result most NP will be no longer retained as free particles
on the epithelium.
As a result insoluble NP may stay for months and years in
the lungs. The most prominent clearance pathway out of
the alveolar region is NP transport by alveolar macro-
Regional deposition of inhaled NP with diameters between 1 nm and 1000 nm for nose an for mouth br athing in th  extrathoracic a rways (ET), the b onc ial ai way (Bb) and the lve l r region (AI) duri g breathing at s , as predictedby ICRP 66 model (ICRP, 1994)Figure 6
Regional deposition of inhaled NP with diameters between 1 
nm and 1000 nm for nose and for mouth breathing in the 
extrathoracic airways (ET), the bronchial airways (Bb) and 
the alveolar region (AI) during breathing at rest, as predicted 
by ICRP 66 model (ICRP, 1994).
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Diagram to illustrate the likely relationship between the 
three main characteristics of combustion derived NP and 
their ability to cause inflammation.
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phages to the larynx where they will be swallowed and
excreted after passage through the gastro-intestinal tract).
In addition, current discussion focuses on another trans-
port function of the vesicular caveolae that transport from
the luminal to the mucosal side of epithelial and endothe-
lial cells. Transport within caveolae for macromolecules
with molecular radii of several nanometres seems to exist
across the alveolar-capillary barrier as a pathway for pro-
tein delivery from lung to blood. This might be another
mechanism for solid UFP transport, given that the open-
ings of the caveolae range between 0.04 and 0.1 μm.
Translocation from lung to the blood
Conflicting studies have been reported regarding particle
translocation after inhalation of NP in the lung, reviewed
recently by Borm & Kreyling [75]. Oberdörster and co-
workers observed rapid translocation towards the liver of
more than 50% of 13C-labeled NP (26 nm size) within 24
hours in a rat model [76]. Kreyling and co-workers, how-
ever, observed only minute (< 1 %) translocation of irid-
ium NP (15–20 nm size) into the blood of rats reaching
not only liver but also spleen, kidneys, brain and heart
[53]. Conflicting results in human studies are also
reported. Nemmar et al [34] demonstrated a rapid 3 – 5 %
uptake of radiolabeled carbonaceous NP into the blood-
stream within minutes of exposure and subsequent
uptake in the liver. In contrast, neither Brown et al [77]
nor Mills et al [78] could find any detectable particulates
(<1% of inhaled NP, limit of detection) beyond the lungs
and cleared fractions via airways and gastro-intestinal
tract using similar carbonaceous NP as Nemmar et al.
However, Nemmar and co-workers demonstrated in their
hamster model, the importance of surface properties like
charge since polar surface showed different translocation
rates across the respiratory epithelium into circulation
[34].
4.2.3. Uptake in the Gastrointestinal tract (GI-tract)
Nanoparticles and microparticles (0.1–3 um) are ingested
at high levels per person per day and it is estimated that
1012-1014 microparticles are ingested per person per day in
the Western world [79], and concerns mainly silicates and
titanium dioxide. They are scavenged by M-cells overlying
the intestinal mucosa and in this way circumvent active
uptake by intestinal epithelium. A GI route of transloca-
tion of ingested ultrafine particles to the blood, is sup-
ported by studies in rats and humans that have shown
that TiO2 particles (150–500 nm) taken in via food can
translocate to the blood and are taken up by liver and
spleen [80,81]. Furthermore, earlier studies by Volkhe-
imer [82] described a mechanism of persorption in epi-
thelial cells of the GI tract by which even larger particles
are taken up into lymphatic and blood circulation and
translocate to the liver and other organs. Recently, nanoc-
rystals have become the subject of intense investigation
for oral administration of drugs and functional food com-
ponents. Drugs or food constituents are produced in 100
% pure form in nanocrystals, by precipitation or other
processes [83]. Since they prove to be very efficient in
vivo, and easy to produce their production for oral appli-
cation is expected to increase considerably.
In contrast, the studies by Kanapilly and Diel [84] and by
Kreyling et al. [53] with ultrafine radioactive metal parti-
cles did not show significant translocation from the GI
tract to other organs via the blood circulation; nor do
these studies show significant translocation to extrapul-
monary organs of ultrafine metal particles deposited in
the lung. The latter study [53] was done with ultrafine
192Ir particles and soluble 192IrCl3 after administration by
gavage in comparison to inhalation or intravenous injec-
tion. Phosphate-buffered saline suspensions of ultrafine
192Ir particles (5 kBq, 0.2 ml) were administered into the
oesophagus of 8 rats. In all of the subsequent biokinetic
studies complete faecal and urinary excretion was col-
lected separately. At given time intervals rats were sacri-
ficed, dissected, and a complete balance of 192Ir activity in
all organs, tissues, blood samples, and excreta was meas-
ured gamma spectroscopically. Rats were anesthetized
with isoflurane as already described. After oesophageal
administration of ultrafine 192Ir particle suspension, vir-
tually the whole amount of 192Ir was found in faecal excre-
tion within 2–3 d. During the 6-d observation period no
detectable 192Ir in urine was observed at any day. Six days
after administration there was no detectable 192Ir in any
organ or tissue of the body. Hence, it was concluded that
for these particles there was no uptake and/or absorption
from the GI tract. It needs to be mentioned however, that
Penetration pathways of topically applied substances through the skinFigure 7
Penetration pathways of topically applied substances through 
the skin.
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for the same particles (18 nm 192Ir) also virtually no pul-
monary translocation took place.
4.2.4 Dermal uptake
In principle there are three possible penetration pathways
of topically applied substances through the skin: the inter-
cellular penetration, the intracellular penetration, and the
follicular penetration.
In the past, the penetration processes were described as a
diffusion through the lipid layers of the stratum corneum
[85]. Liposomes with a diameter between 20 nm and 200
nm were found to be active carriers of topically applied
drugs into the living epidermis via the intercellular pene-
tration route [86]. Initially, it was presumed that the fol-
licular penetration does not play a dominating role in this
process, because the amount of hair follicles of the total
skin surface was estimated to be not more than 0.1% of
the total skin surface area [87]. However, several in vitro
and in vivo studies suggested a potential role of follicular
penetration in the dermal penetration process. Feldman
[88] and Maibach [89] observed regional variations of
percutaneous absorption in different skin areas. They
assumed that the density and size of hair follicles might be
the reason for their findings. Hair follicle mediated uptake
is further discussed in the paragraph on dermal effects of
NP.
The on-line, in vivo investigation of the distribution of
topically applied formulations containing Nanoparticles
on the skin surface became possible by the use of fibre-
based laser scanning microscopes. In this case the optical
imaging and scanning system is incorporated into a hand
piece, which can be applied to any skin area [90]. A skin
surface treated with a formulation containing ethanol and
a formulation containing Nanoparticles is presented in
Figure 8. In the first case, the corneocytes of the skin sur-
face were easy to recognize. When a formulation contain-
ing NSP was applied, a thin protection film covers the skin
surface.
Dermal uptake of NP through hair follicles
As previously mentioned, dermal absorption/penetration
processes have been described as a diffusion process
through the lipid layers of the stratum corneum (4. x) Fol-
licular penetration was previously believed to play a
minor role in percutaneous penetration, given that hair
follicles were estimated to occupy less than 0.1% of the
total skin surface area. However, several studies suggested
that follicular penetration might contribute to the overall
penetration rate. For example, Feldman [88] and Maibach
[89] found regional variations of percutaneous absorp-
tion in different body areas and assumed that, in addition
to skin thickness, the density and size of hair follicles con-
tribute to the differences in penetration rates.
A recent observation of cadmium sulphide particle depo-
sition in follicles [87] prompted further investigations on
follicular penetration of solid particles. The results sug-
gested that, after application of a fine material of a diam-
eter of less than 1μm in an appropriate vehicle, the
material is mainly found in the upper parts of the horny
layer as well as in follicular orifices. A material with a par-
ticle diameter of 3 to 10 μm was observed in the follicle
orifices only, whereas material of more than 10 μm in
diameter also remained on the skin surface. This observa-
tion was made for several materials, including adapalene
(a synthetic retinoid) crystals, polystyrene beads, aniline
dansylate as well as benzoyl peroxide. It is conceivable
that from this follicular reservoir soluble compounds may
further diffuse into the viable layers of the skin.
Lademann et al. [91] investigated the penetration of
coated titanium dioxide NP into the stratum corneum of
living human skin by tape stripping and biopsies in com-
bination with spectroscopic measurements. After applica-
tion of a sunscreen containing TiO2 NP, the largest
amount of coated titanium dioxide was localized in the
upper part of the stratum corneum, although minimal
amounts of TiO2 could be detected on tapes obtained at
the end of the stripping procedure as shown in figure 9.
Small white spots of sunscreen material could be observed
visually in some follicle orifices after removing several
strips from the treated skin surface, suggesting that TiO2
was present in the orifices. In order to investigate the con-
centration of TiO2 in follicles, the distribution of the TiO2
NP on tape strips from different parts of the stratum cor-
neum was analysed after staining with OsO4 [91]. Pres-
ence of TiO2 in pilosebaceous orifices could be shown on
tape strips from the lower parts of the stratum corneum.
The coating material of the TiO2 Nanoparticles on the tape
strips emitted a typical fluorescence, which allowed the
detection of Nanoparticles in stained areas of the orifices
by laser scanning microscopy (figure 10).
On corneocytes outside the follicle channels or adhesive
film from areas not covered with corneocytes, no fluores-
cence was detected. Skin biopsies were collected in order
to localise TiO2 in deeper parts of the epidermis. Three
characteristic areas could be distinguished by X-ray fluo-
rescence microscopy, i.e.:
• Stratum corneum: presence of titanium dioxide NP
• Interfollicular epidermal tissue below the stratum cor-
neum: absence of titanium dioxide NP
• Follicles: in approximately 10% of follicles fluorescence
was observed suggesting presence of titanium dioxide The
titanium concentration decreased in the lower regions of
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these follicles. Detected TiO2 concentrations inside the
follicles were by two orders of magnitude lower than
those in the upper part of the horny layer.
A penetration of Nanoparticles through the horny layer
could not be detected by X-ray fluorescence. Overall, even
these highly sensitive methods failed to detect a penetra-
tion of titanium dioxide particles into living tissue of
human skin [91]. These data also confirmed the results of
an earlier study, which detected no percutaneous absorp-
tion of particles in skin samples from humans treated with
a microfine titanium oxide-containing sunscreen [92]. A
more recent study on the percutaneous penetration of two
different micronised titanium dioxide preparations used
in sunscreens (a) particle size of 10 to 15 nm, which aggre-
gated to particles of approximately 100 nm, and b) parti-
cle size of approximately 100 nm) revealed that these
particles remained on the surface of the stratum corneum,
and did not penetrate into the stratum corneum or living
compartments of the skin [93]. The absence of skin pene-
tration of NP is also consistent with the results of a recent
study that measured in vitro the percutaneous penetration
of micronised zinc oxide (mean particle size: 40 nm)
through pig skin. The study found no measurable penetra-
tion of zinc oxide NP into the viable parts of the skin
(BASF Study No 52H0546/032193, 2004, unpublished).
Although it cannot be excluded that the physical proper-
ties of NP may enhance the absorption/penetration of cer-
tain substances applied to the skin, such as reported for
methanol or octanol [94], the results of available studies
suggest that, although small particles may be deposited on
the follicle orifice, they do not penetrate the skin via the
follicle. This was confirmed by the results of a recent
study, which showed that although polystyrene NP (20 to
200 nm) accumulated in the follicle orifices, the particles
did not penetrate into the skin or the follicle [95].
4.2.5 Uptake in the Central Nervous System (CNS)
NP may be taken up directly into the brain by trans-syn-
aptic transport, as pointed out in recent publications [33]
Such a mechanism was first reported in 1947 for 0.03-μm
polio virus in monkeys and was later described for nasally
deposited colloidal 0.05-μm gold particles moving into
the olfactory bulb of squirrel monkeys. Carbonaceous NP
may translocate along the same pathway to the central
nervous system (CNS), based on their presence in the
olfactory bulb of rats after inhalation [33]. These authors
suggest that Nanoparticles gain access from the olfactory
epithelium to the olfactory lobe via the olfactory nerves.
The olfactory epithelium, a 2.5 cm2 patch in the human
nasal passage, is a ciliated pseudo stratified columnar type
containing few or no goblet cells. Three cell types are
present, the olfactory cell, support cell and basal cell of
which only the olfactory cell is chemoreceptive. The olfac-
tory cells are actually quasi-neurones, the axons of which
bundle together to make the olfactory nerve leading to the
olfactory lobe. The olfactory lobe is a projection of the
lower anterior portion of each cerebral hemisphere, which
In vivo investigation of the distribution of a formulation containing ethanol (left picture) and Nanoparticles (right picture) on the surfac  of human skinFigure 8
In vivo investigation of the distribution of a formulation containing ethanol (left picture) and Nanoparticles (right picture) on 
the surface of human skin.
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is responsible for processing the nerve impulses relating to
the sensation of smell. Neurones are commonly labelled
using the retrograde transport along axons of large mole-
cules such as HRP, suggesting that these cells may have the
capacity to transport Nanoparticles. In fact single particle
tracking has been used to study the transport of glutamate
receptors in neurones.
Access of Nanoparticles to neural tissue via the blood
brain barrier (BBB) is also possible. Of all the endothelial
barriers within the body, the BBB is the tightest, contain-
ing specialised tight junctional proteins to minimise para-
cellular transport. Unless the BBB is compromised the
main route of access to the brain for all molecules (except
small lipophillic substances such as alcohol) is via a tran-
scellular route, usually involving specific transport pro-
teins. Studies by [96] suggest the presence of a
physiological barrier at the basal lamina, analogous to the
podocyte in the kidney, that is distal to the anatomic tight
junction of the BBB. Using magnetic Nanoparticles and
MRI to image their distribution, these studies suggest that
the physiological barrier may limit the distribution of
some proteins and viral particles after transvascular deliv-
ery to the brain, suggesting that the healthy BBB contains
defence mechanisms protecting it from blood borne nan-
oparticle exposure. A number of pathologies, including
hypertension and allergic encephalomyelitis, however
have been associated with increased permeability of the
BBB to Nanoparticles in experimental set ups.
4.2.6 Chronic secondary delivery of NP
Some studies[97,98] described a very small but detectable
fraction of NP (192Ir) that translocated to secondary target
organs like the liver, spleen, brain, and kidneys of about
0.002 each. For these extrapulmonary organs, a peak was
found at day 7 after inhalation. Long-term retention data
showed no further accumulation, but a net clearance from
these target organs was found with time and decreased to
close to the limit of detection. As shown in the previous
investigation [99] the iridium UFP were virtually insolu-
ble. To distinguish between the soluble and particulate
fraction, they performed the same analysis as previously
and they were able to detect a particulate fraction which
decreased with time [99].
Penetration of NP-size coated titanium dioxide into the horny layer 1 hour after long-term sunscreen applicationFigure 9
Penetration of NP-size coated titanium dioxide into the horny layer 1 hour after long-term sunscreen application.
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4.2.7. Protein absorption and uptake of NP
Intensive studies had been performed on the systemic
translocation of 1- to 4-nm actinide oxide particles from
the rat lungs after instillation into the trachea [100,101].
Rapid systemic 24-h translocation of particles bound to
either a complex pattern of proteins and/or components
of surfactant was observed depending on parameters of
particle material and surface properties like the net charge
of the particles. The authors clearly emphasize the need to
distinguish between absorption of dissolved particle
material chelated by citrate anions and proteins like trans-
ferrin and particles bound to surfactant components and
a protein pattern, which they were unable to resolve. They
discuss epithelial pores in the size range of 1 nm as a
potential pathway. Besides those pathways, active trans-
port of particle-protein complexes also needs to be con-
sidered.
Engineered Nanoparticles have also been developed as
devices to deliver drugs and proteins across the GI-tract
and liver, to prevent complete degradation (review: Dun-
can, 2004) [102]. This is related to the fact that Nanopar-
ticles with their large surface will bind or adsorb proteins,
which may then function as receptor-agonists [103] or
adsorption may protect the protein from recognition by
digestive enzymes. The ability of NP to adsorb proteins is
dependent on the particle coating [83]. On the other hand
after release of the carrier protein, NP can interact with
endogenous proteins at the site of deposition. NP below
40 nm have a size comparable to large proteins, therefore
leading to the following hypotheses:
• Depending on NP surface properties, NP may complex
different endogenous proteins
• Different NP-protein-complexes may have different
biokinetics including translocation across membranes
• Endogenous proteins of these complexes may have a dif-
ferent activity or even different function.
Preliminary studies using different ultrafine particles indi-
cate that these bind differently to a number of proteins in
native rat broncho-alveolar lavage fluid (Kreyling, per-
sonal communication). If these studies are confirmed the
biokinetics of different NP-protein complexes could pro-
vide the basic explanation for the different observed trans-
location patterns described by the various studies as
reviewed in chapter 5. At the same time functional
changes in proteins in such complexes may be another
mechanism by which particularly small NP with their
large surface area as a binding interface may induce pro-
tein mal-functioning which may lead to the pathogenesis
and adverse health effects. Figure 11 illustrates some of
the theoretical possible scenarios.
4.2 8 Elimination and kinetics of NP
On reaching the blood, Nanoparticles may be eliminated
by different mechanisms which are dependent on the
route of absorption and their surface properties. For
example, absorption via the lung, skin or gut could be as
particles contained within phagocytic cells such as macro-
phages, as free single or aggregated particles, or particles
associated with serum proteins. Free single or aggregated
particles are likely to be removed from the circulation via
phagocytic cells in the reticuloendothelial system and
hence will accumulate in organs such as the liver. It is
unlikely that Nanoparticles will remain as discrete single
particles in the body since they are likely to be coated very
quickly in biological molecules such as proteins. Nano-
particles contained within i.v. preparations are likely to be
formulated to allow targeting to specific compartments
within blood and accumulation within specific target
organs or tissues such as tumours. This targeting may be
achieved through surface modification of the Nanoparti-
cles.
In terms of toxicology and pharmacology, metabolism
usually refers to the chemical alteration of a xenobiotic via
Superposition of the transmission and fluorescence image of a pilosebaceous orifice on a 25th removed tap  strip stainedwith OsO4 btained by la er sca ni g micros opy, the d stri-b i n f ta ium oxide coating inside the mark of a piloseac ou  orifice s s en s red spotsFigu  10
Superposition of the transmission and fluorescence image of 
a pilosebaceous orifice on a 25th removed tape strip stained 
with OsO4 obtained by laser scanning microscopy, the distri-
bution of titanium dioxide coating inside the mark of a pilose-
baceous orifice is seen as red spots.
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enzymatic mechanisms. The chemical alteration of inor-
ganic Nanoparticles, such as TiO2 is unlikely, although
any chemical groups added to the particle surface could be
modified enzymatically or non-enzymatically within the
body. As for polymers, the enzymatic alteration of these
substances is likely to be very specific to the polymer com-
position and characteristics. Fullerenes have been shown
to be metabolized in aquatic systems and it is therefore
assumed that carbonaceous NP especially those with
branched side chains or hydrophilic groups are targets for
normal human metabolic machinery, which is driven by
oxidative enzymes [104].
The most common route of excretion for xenobiotics is
via the kidneys into urine. This process involves filtration
of the blood through a complex filtration membrane in
the glomerulus of kidney nephrons. The size of the
fenestrae within the glomerular filter is limited to allow
the passage of small molecular weight substances whilst
preventing the filtration of larger molecules such as pro-
teins. For substances up to a molecular weight of 7,000
Dalton the filter allows free filtration, above 7,000 D fil-
tration is retarded, and above 70,000 D filtration is insig-
nificant. Poly(amidoamine) (PAMAM) dendrimers, 5 nm
in diameter have been shown in a mouse model to be
excreted via urine with accumulation in kidney observed
[105]. Some studies have suggested that drugs can be tar-
geted to the kidney by incorporation in Nanoparticles to
facilitate uptake by glomerular essential cells [106,107],
however the short or long-term impact of accumulation
within the filtration apparatus on renal function has not
yet been addressed. It is conceivable that particles of an
appropriate size could easily block the renal fenestrae
leading to rapid kidney failure and death. Unpublished
observations by some research groups suggest that this is
a realistic process (Curtis, personal communication). Sur-
face or charge modifications of the Nanoparticles may
help to prevent association of the particles with the filtra-
tion membrane.
Excretion of xenobiotics from the body also occurs via
bile, produced by liver parenchymal cells (hepatocytes)
and secreted into bile ducts before delivery into the gas-
trointestinal tract for excretion in faeces. After oral admin-
istration of polymethyl [1-14C]methacrylate
Nanoparticles to rats [108] radioactivity was detected in
bile and urine, although it was not confirmed that this
radioactivity remained particle bound. Large molecular
weight substances such as horse radish peroxidase (HRP)
are known to gain access to the bile via transcytosis medi-
ated by vesicular transport [109]. It is conceivable that the
same route of transport could be available to Nanoparti-
cles. The studies by Lowe et al., [109] also indicate that
liver damage increases the likelihood of paracellular
routes of entry for HRP into bile.
4.2. Summary
After inhalation, oral administration or parenteral admin-
istration NP can get access to the lung, gastrointestinal
tract and brain. Dermal exposure and uptake is being
debated as an important uptake route for NP, since NP are
present in many cosmetic products as vehicles for mois-
turizers or in shampoos, detergents or sunscreens. Up to
now, dermal uptake of Nanoparticles has not been dem-
onstrated beyond the submucosa. No studies have been
conducted to address the question whether Nanoparticles
topically applied to human skin can reach the dermal
compartment and via that route enter the circulation.
Given the high bioavailability of Nanoparticles, however,
these studies are of obvious importance, in particular with
regard to individuals with a skin barrier defect such as
atopics.
The uptake and transport mechanisms in the lung and GI-
tract differ qualitatively and quantitatively from fine par-
ticles. Transport within caveolae for macromolecules with
molecular radii of several nanometres seems to exist
across many barriers as a pathway for protein delivery
from lung to blood [110]. This might be another mecha-
nism for solid NP transport, given that the openings of the
caveolae range between 0.04 and 0.1 μm.
Non-soluble Nanoparticles can stay for years in the lungs,
GI-tract or brain; they are less well taken up by profes-
sional macrophages of the defence system but interact
with cells of the epithelium, the interstitial tissue and vas-
cular cells allowing pro-inflammatory reactions of these
cells which usually do not see any particles. In addition,
Nanoparticles can bind to proteins or translocate into the
circulation and reach secondary target organs like liver,
spleen, kidneys, heart and brain; rates and fractions are
still under debate and depend particularly on the chemi-
cal and surface properties of Nanoparticles.
4.3 Effects of nanoparticles
4.3.1. Pulmonary effects
Pulmonary toxicity studies in rats demonstrate that
ultrafine particles (generally synonymous with the term
"Nanoparticles" (see Chapter 1) produce enhanced
inflammatory responses when compared to larger-sized
particles of identical chemical composition at equivalent
mass concentrations [111,112]. Surface area and particle
number determinations appear to play important roles in
ultrafine particle lung toxicity. Contributing to the effects
of ultrafine particle toxicity is their very high size-specific
deposition rate when inhaled experimentally as singlet
ultrafine particles rather than as aggregated particles.
Some evidence suggests that inhaled ultrafine particles,
after deposition in the lung, largely escape alveolar mac-
rophage surveillance and gain greater access to the pulmo-
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nary interstitium through translocation from alveolar
spaces through epithelium [111,112].
A limited number of studies have been reported which
have assessed the inhalation toxicity of ultrafine particles
by laboratory animals at very high particle concentrations.
Some hazard-based toxicity studies were conducted to
investigate pulmonary effects caused by lung particle over-
load, i.e., induction of lung tumours in rats at high
retained particulate lung burdens, Specifically, chronic
inhalation studies with ultrafine (P-25) or fine-sized TiO2
particles (average primary particle sizes ~ 20 nm and ~
270 nm, respectively) have shown that less than one-tenth
the inhaled mass concentrations of the aggregated
ultrafine particles, compared with the fine particles, pro-
duced equivalent numbers of lung tumours in rats in
these 2-year studies (approximately 16–30%) [113,114].
In addition, shorter-term pulmonary toxicity studies with
ultrafine and fine carbon black, nickel, as well as TiO2 par-
ticles in rats [115-117], have demonstrated enhanced lung
inflammatory potency of the ultrafine particles when
compared to fine-sized particulates of similar composi-
tion. When the instilled doses were expressed in terms of
particle surface area, the responses of the ultrafine and
fine TiO2 particles fell on the same dose-response curve.
This is because a given mass of ultrafine particles has a
much greater surface area when compared to the same
mass of fine-sized particles and therefore is more likely to
cause particle overload in the lung. Thus, from a toxico-
logical and regulatory viewpoint, it will be important to
delineate the pulmonary effects of ultrafine particles in
rats at overload vs. non-overload conditions.
Systematic comparison of fine and ultrafine particles
It may be surprising to note that the toxicity database for
systematic comparisons of the pulmonary effects of
ultrafine/Nanoparticles vs. fine-sized particles in rats is
sparse- and consists of studies on only two particle-types:
namely titanium dioxide and carbon black particles [75].
Moreover, the rat model, for which most if not all of the
nano vs. fine size comparisons have been reported, is
known to be an extremely sensitive species for developing
adverse lung responses to particles, particularly at over-
load concentrations. As a consequence, chronic (two-
year), high-dose, inhalation exposures in rats with poorly
soluble, low toxicity dusts can ultimately produce pulmo-
nary fibrosis and lung tumours via an "overload" mecha-
nism. The tumour-related effects are unique to rats and
have not been reported in other particle-exposed, rodent
species such as mice or hamsters, under similar chronic
conditions. It has been postulated that the particle-over-
load effects in rats result in the development of "exagger-
ated" lung responses, characterized by increased and
persistent levels of pulmonary inflammation, failed clear-
ance, cellular proliferation, fibro-proliferative effects, and
inflammatory-derived mutagenesis, and this ultimately
results in the development of lung tumours.
Role of surface chemistry
To complicate further the issue of nanoparticle toxicity,
the results of recent pulmonary bioassay studies in rats
suggest that, on a mass basis, not all nanoparticle-types
are more toxic than fine-sized particles of similar chemical
composition. As mentioned previously, the limited num-
bers of studies that have been reported suggest that
ultrafine (P-25) TiO2particles produced greater pulmo-
nary inflammation when compared with fine-sized TiO2
particles. However, in contrast to the conclusions of the
earlier studies with P-25 type ultrafine TiO2 particles, the
results of recent preliminary studies comparing the effects
of nano- vs. fine-sized particles, have indicated that pul-
monary exposures in rats to uncoated TiO2 nanoscale rods
(200 nm lengths × 30 nm diameters) and TiO2 nanoscale
dots (particle size < 30 nm) did not produce enhanced
lung inflammation in rats when compared to fine-sized
TiO2 particle exposures (particle size ~ 270 nm). In gen-
eral hydrophobic TiO2 seems to be less inflammatory than
naive TiO2, regardless of particle size [118,119].
Using a similar pulmonary bioassay protocol, lung bio-
assay studies have compared the toxicity effects in rats of
uncoated nanoscale quartz particles (50 nm) vs. fine-sized
quartz particles (particle size ~ 1600 nm). Accordingly, at
equivalent mass doses, the nanoquartz particles produced
less intensive and sustained pulmonary inflammatory and
cytotoxic responses when compared to the effects pro-
duced by the Min-U-Sil quartz particles [120]. These pre-
liminary findings are intriguing since crystalline quartz
silica particles are classified as a Category 1 human carcin-
ogen by the International Agency for Research on Cancer
(IARC)[40]. However, also recent work with surface mod-
ified fine quartz has demonstrated that both acute and
chronic inflammation and genotoxicity [121] is inhibited.
A number of factors are likely to influence the pulmonary
toxicity of Nanoparticles. These include:
1) Particle number and size
2) Surface dose
3) Surface coatings on particles, particularly for engi-
neered nanoparticulates [122];
4) The degree to which ambient ultrafine particles "age"
and become aggregates, or engineered Nanoparticles
aggregate/agglomerate, due in large part to surface charac-
teristics;
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5) Surface charges on particles, as well as particle shape
and/or electrostatic attraction potential (as is the case for
engineered single-wall carbon nanotubes- which readily
agglomerate [123].
6) Method of particle synthesis (i.e., whether formed by
gas phase (fumed) or liquid phase (colloidal/precipi-
tated) synthesis and post-synthetic modifications.
The degree to which engineered Nanoparticles aggregate
in the ambient aerosol or occupational environment and
subsequently do or do not disaggregate following inhala-
tion and particle deposition in the lung will strongly influ-
ence particle deposition rates and patterns as well as
interactions with lung cells. If the ultrafine/Nanoparticles
disaggregate upon interaction with alveolar lung fluids at
sites of particle deposition (i.e., alveolar duct bifurca-
tions), then they could behave as discrete individual Nan-
oparticles and may stimulate enhanced inflammatory cell
recruitment and/or the particles could preferentially trans-
locate to more vulnerable anatomical compartments of
the lung. Alternatively, aggregated nanoparticle-types
could behave as fine-sized particles. On the other hand
most inhalation and instillation studies have been done
with aggregated particles and in these instances, the NP
(based on primary particle diameter) cause more inflam-
mation.
Schematic presentation of potential interactions between Nanoparticles and proteinsFigure 11
Schematic presentation of potential interactions between Nanoparticles and proteins. The first example shows the intended 
(covalent) binding of a protein to an NP as a drug-delivery-tool. The second example shows how proteins may absorb on the 
NP surface, thereby masking the particle properties and loosing functional protein. The third example shows how NP can bind 
and breakdown proteins, through their active surface area [15].
Coupled NP-protein-
complex
• protein function unchanged
• active NP surface area
• less likely protein-mediated
translocation across membranes
Masked NP-protein-
complex
• protein function unchanged 
• covered NP surface
• possible protein-mediated
translocation across membranes
NP
NP
NP
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In summary, there exists a paucity of relevant data on the
pulmonary effects of inhaled Nanoparticles (Table 5).
Particle size is an important factor but is only one of many
variables that determine health effects. As a consequence,
no general conclusions regarding nanoparticle toxicity
can be made at the present time. Therefore, it is important
that evaluations of safety and health risks of newly devel-
oped engineered nanoparticulates should be made fol-
lowing relevant testing on a case-by-case basis for each of
the nanoparticle-types.
4.3.2 The reticulo- endothelial system
The reticulo-endothelial system consists of cells that have
the ability to phagocytose cellular debris, aged cells, path-
ogens and foreign substances including inert particles
from the blood stream. Such cells include macrophages,
monocytes, and specialised endothelial cells that line
organs such as the liver, spleen and bone marrow. The
reticulo-endothelial system located in the liver is exposed
to all Nanoparticles absorbed from the gastrointestinal
tract (GIT) into the cardiovascular system, since all blood
exiting the GIT does so in the hepatic portal vein that
directly perfuses the liver. The main function of this sys-
tem is thought to be the removal and neutralization of
any potential pathogens that enter the body from the GIT
microflora. However, these cells have the capacity to
phagocytose Nanoparticles. The consequences of nano-
particle uptake by these macrophages is not yet known,
however there is evidence from in vitro studies that low
solubility, low toxicity Nanoparticles such as carbon black
and polystyrene stimulate the macrophages via reactive
oxygen species and calcium signalling, to make pro-
inflammatory cytokines such as tumour necrosis factor
alpha [124]. Oxidative stress is known to inhibit hepato-
cyte function and bile formation [125], while pro-inflam-
matory cytokines are also associated with the pathology of
liver disease. Hence, the impact of Nanoparticles on the
liver and reticulo-endothelial system needs to be investi-
gated.
4.3.3 Cardiovascular effects and haematocompatibility
Ligand coated engineered Nanoparticles are being
explored for decades as agents for molecular imaging or
drug delivery tools. This has led to a considerable under-
standing of particle properties that can affect penetration
in tissue without affecting tissue function. A size-depend-
ent NP penetration in aorta vessel wall was noted after
local delivery of polystyrene NP [126]. A more sophisti-
cated approach for imaging of angiogenesis is achieved by
integrin-targeted paramagnetic ironoxide NP [127]. Simi-
larly cationic NP, including gold and polystyrene have
been show to cause haemolysis and blood clotting, while
usually anionic particles are quite non-toxic. This concep-
tual understanding maybe used to prevent potential
effects of unintended NP exposure. Similarly, drug loaded
Nanoparticles have been used to prolong half-life or
reduce side-effects and have shown which particle proper-
ties need to be modified to allow delivery, while being
biocompatible (review:[128] Also this know-how can
help to develop engineered Nanoparticles for other appli-
cations that are with low hazard.
On the other hand, there is need to find explanations for
the increased risk of patients with CV diseases upon expo-
sure to PM and/or traffic. Cardiovascular effects of
(inhaled) NP have been described only in human panel
and animal studies, but the well-established cardiovascu-
lar effects of PM10, described in human epidemiological
studies, has not yet been linked to the NP component. In
addition, experimental animal studies with combustion
NP do show that high exposures to diesel soot NP or other
surrogate NP causes observable cardiovascular effects.
However these are invariably seen in experimental ani-
mals given high doses, often by instillation into the lungs
or the blood. Several toxicological studies have demon-
strated that combustion and model NPs can gain access to
the blood following inhalation or instillation and can
enhance experimental thrombosis. Diesel particles
instilled into hamster lungs also enhance thrombosis but
Table 3: Public funds for R&D in nanoscience and nanotechnologies
Country Public funding
Europe Current funding ~ €1 B, largely from national and regional programmes
Japan $400 M (2001); $800 M (2003); $1 B (estimated for 2004)
USA $750 M (2003); $3.7 B (2005–2008, excluding defence)
Data source: http://www.bccresearch.com/editors/RGB-290.html
Table 2: Global R&D expenditure [$M]
Country/Region 1997 2002
USA 432 604
Western Europe 126 350–400
Japan 120 750
South Korea 0 100pa (for 10 yrs)
Taiwan 0 70
Australia 0 40
China 0 40
Rest of world 0 270
see http://www.bccresearch.com/editors/RGB-290.html
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it is not clear whether this was an effect of pulmonary
inflammation or particles translocated to the blood
[129,129-131]. High exposures to DEP by inhalation
caused altered heart rate in hypertensive rats [132] inter-
preted as a direct effect of DEP on the pacemaker activity
of the heart. Inflammation in distal sites has long been
associated with destabilization of atheromatous plaques
and instilled high doses of PM in Watanabe rabbits cause
morphological evidence of atheromatous plaque destabi-
lisation [133]. Ultrafine carbon black instilled into the
blood has been reported to induce platelet accumulation
in the hepatic microvasculature of healthy mice in associ-
ation with prothrombotic changes on the endothelial sur-
face of the hepatic microvessels [134] Inhalation exposure
to diesel nanoparticles caused endothelial dysfunction
measuerbal in the forearm as well as a decrease in stimu-
lated tPA release
4.3.4 CNS effects
As discussed previously inhaled Nanoparticles can gain
access to the brain by two different mechanisms:
• transsynaptic transport after inhalation through the
olfactory epithelium, and
• uptake through the blood-brain barrier
The first pathway has been studied primarily with model
particles such as carbon, Au and MnO2 in experimental
inhalation models. The second pathway has been the
result of extensive research and particle surface manipula-
tion in drug delivery, as an approach to try and get drugs
to the brain [83,135] The latter studies suggest that the
physiological barrier may limit the distribution of some
proteins and viral particles after transvascular delivery to
the brain, suggesting that the healthy BBB contains
defence mechanisms protecting it from blood borne nan-
oparticle exposure. A number of pathologies, including
hypertension and allergic encephalomyelitis, however
have been associated with increased permeability of the
BBB to Nanoparticles in experimental set ups. Conversely,
the nanoparticle surface charges has been shown to alter
blood-brain integrity [136] and need consideration as to
their role in brain toxicity and brain distribution.
The use of paramagnetic Nanoparticles for MRI imaging
of different cell types within neural tissue has proved use-
ful experimentally[137], and it has been suggested that
this might be useful in humans to track, for example, the
development of stem cell grafts used to treat neurodegen-
erative diseases. However, the potential impact of Nano-
particles on human neuronal tissue is as yet not
investigated in detail. Nanoparticles have been shown to
induce the production of reactive oxygen species and oxi-
dative stress and oxidative stress has been implicated in
the pathogenesis of neurodegenerative diseases such as
Parkinson's and Alzheimer's [138]. It is conceivable that
the long term effects might include a decrease in cognitive
function. Evidence for such effects is presented by studies
in biopsies from city dwellers and Alzheimer's like pathol-
Table 5: Comparison of attributes of lung overload in rats vs. larger mammals such as dogs and primates (nonhuman and human) for 
particles with low solubility
Classical attributes and sequelae of lung overload in rats Rats Dog, monkey and man
Chronic pulmonary inflammation yes not certain
Hyperplasia of macrophages and epithelial cells yes not certain
Altered pulmonary clearance (overwhelmed) macrophage mediated clearance yes probably not
Large alveolar burdens of particles yes probably not
Increased interstitialization of deposited particles yes yes- greater % than rat
Increased translocation of particles from lung to thoracic lymph nodes probably probably
Interstitial lung disease (fibrosis) yes yes but less severe
Production of lung tumours yes no
Table 4: Surfactants commonly used to stabilise Nanoparticles during their synthesis.
Substance Dispersible in:
4-Dimethylaminopyridine Water
Mercaptoundecaneacid Water
Thiols (e.g. Dodecanethiol) Unpolar solvents like Hexane, Toluene, Chloroform, Acetone
Tetraalkylhalogenides Unpolar solvents like Hexane, Toluene, Chloroform, Acetone
Fluoralkanes Unpolar solvents like Hexane, Toluene, Chloroform, Acetone
Trialkoxy-Silanes and derivates thereof Water, Alcohol
Phosphorous containing substances like Ph2PC6H4SO3Na pH dependent in water or unpolar solvents
Aminoalkanes and derivates thereof Dependent on functionalisation unpolar solvents or Alcohol
These substances are likely to be on the surface throughout the lifetime of the particle
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ogy have demonstrated increased markers of inflamma-
tion and AB42-accumulation in frontal cortex and
hippocampus in association with the presence of Nano-
particles [129]. Additionally, inhalation exposure of
BALB/c mice to with particulate matter showed that acti-
vation of pro-inflammatory cytokines in the brain of
exposed mice [139]. Whether this is due to the fraction of
combustion Nanoparticles remains to be investigated.
4.3.5 Dermal effects of NP
Particles with a size of approximately 50–500 nm are
widely used in cosmetic products, in order to improve the
homogeneity of the distribution of the formulations on
the skin surface, or to act as UV filters against sun radia-
tion. Some of the particles are included in the definition
of NP as indicated above and are often used in sunscreens
and skin care products for daily use. The concentration of
the Nanoparticles in formulations is generally less than
3%. Sunscreens are applied onto the skin at a concentra-
tion of 1 mg/cm2 or less. The particles act as "nanomir-
rors" on the skin and partly reflect the sunlight. The
discussion on dermal effects of these NP mainly focussed
on the question whether these particles are able to pene-
trate into or through the skin.
Because of their scattering properties, NP increases the
optical pathway of UV photons entering the upper part of
the horny layer. In this way, more photons are absorbed
by the stratum corneum and by the applied organic filter
substances. Therefore coated titanium dioxide Nanoparti-
cles are commonly used as UV filter substances in com-
mercial sunscreen products. In addition, modern
sunscreens usually contain organic UV-filter substances
such as butyl methoxydibenzoylmethane (BMDBM), 4-
methylbenzylidene camphor (MBC). After topical appli-
cation and equilibration, these UV-filters are located on
the surface in the upper part of the stratum corneum
where they form a protective layer [140,141] or especially
in the case of titanium dioxide, they were reported not to
enter the skin [91,93]. The efficacy of sunscreen products
is characterized by the sun protection factor (SPF) [142].
Usually, the SPF of a formulation containing organic and
inorganic filter compounds is higher than the sum of the
sun protection factors of the individual UV-filter sub-
stances [143]. There is a synergistic (or additive) effect
between organic and inorganic UV-filter substances.
Effects of NP- summary
Both animal and human data suggest that NP are able to
cause acute and chronic effects in the lung ranging from
inflammation, exacerbations of asthma to genotoxicity
and carcinogenesis. The tumour-related effects are unique
to rats and have not been reported in other particle-
exposed, rodent species such as mice or hamsters, under
similar chronic conditions. Current epidemiological data
in workers exposed to (pigmentary) TiO2 and CB do not
show increased risks for lung cancer. Although particle
size and surface area seems to be important particle
parameters, currently the understanding of particle prop-
erties in relation to hazards is limited. In addition, it is
important to delineate the pulmonary effects of ultrafine
particles in rats at overload vs. non-overload conditions.
The emerging data on uptake of NP in the brain upon
inhalation present a further challenge to toxicology and
medicine to investigate the functional relevance of this
translocation to CNS function and indirect systemic
effects. The uptake of engineered NP through the blood-
brain barrier is an intended effect in drug delivery and can
only be achieved by very specific surface modifications.
The cardiovascular effects of NP may be related to both
brain uptake as well as direct effects after various uptake
pathways. Research in drug delivery has shown which
engineered NP upon intravenous delivery have little
effects on the cardiovasculature, and this know-how can
be used to manufacture NP without these hazards in other
applications of Nanotechnologies that may lead to expo-
sure and uptake of NP.
NP are widely used in cosmetic preparations applied to
human skin, such as sunscreens. Various NP preparations
of zinc oxide or titanium oxide have been tested in vitro
for percutaneous penetration, phototoxicity or photo-
genotoxicity. At the present state of knowledge, there is lit-
tle evidence that NP in cosmetic products may penetrate
human skin and produce human systemic exposure.
Overall, available data suggest that the human health risk
from the dermal exposure to NP materials is low, but the
published data set certainly needs extension.
5) Environmental impact of nanoparticles
Some Nanoparticles can occur naturally, through com-
bustion or nucleation for instance, and this is the way they
may impact on human health. It is estimated that 50,000
kg/year of nano-sized materials are being produced
through these un-intended anthropogenic sources. In
Chapter 4 the evidence for the role of Nanoparticles in the
effects induced by ambient air pollution was reviewed. On
the other hand, NP are increasingly manufactured and
depending on the techniques used in manufacturing
them, NP could be released in air, water, and ultimately
contaminate soil and food products [144]. In 2003, Sin-
gle-Walled and Multi-Walled Nanotubes had a worldwide
production of 2954 kg. However, the Carbon Nanotech-
nology Research Institute (Japan) plans on expanding
their production from ~ 1000 kg in 2003 to 120,000 kg
per year within the next five years. Although current pro-
duction of engineered nanomaterials is small, it is evident
that production rates will accelerate exponentially in the
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next few years. Considering the tons of engineered nano-
material planned for production, it is likely that some of
these materials will enter the environment during the
product's Life Cycle (manufacture, use, disposal). In addi-
tion to these specifically engineered nanomaterials, nano-
sized particles are also being produced non-intentionally
in diesel exhaust and other combustion processes.
Because of their extreme smallness, strong mobility and
reactivity (Chapter 2), it appears relevant to evaluate risks
related to NP transfer and persistence in the environment.
Yet very little research has been done on environmental
toxicology of engineered nanomaterials. This brief review
serves as an overview of potential problems including bio-
accumulation, bio-toxicity and biodegradability as well
as potential benefits of nanotechnology in Environmental
settings.
5.1 Impacts on environmental species
Few data are available for impacts of engineered nanoma-
terials on environmentally relevant species. No studies to
date have been done on protists, fungi, plants, birds, rep-
tiles, or amphibians, and the only mammalian studies
have been carried out using laboratory species. Only one
study has been done on fish and Arthropods, and no stud-
ies have been done on any other invertebrate phyla. Con-
sidering that invertebrates constitute 95–97% of all
known animal species, there is a considerable lack of
information on ecological endpoints. Only limited infor-
mation is available for bacteria.
Data on environmental impacts of engineered nanomate-
rials are only available for un-coated, water-soluble col-
loids of fullerenes (nC60). These studies show that the
Daphnia magna 48 hour LC50 is approximately 800 ppb
[145], making these fullerenes only moderately toxic.
Largemouth bass (Micropterus salmoides) exposed to up to
1 ppm nC60 showed no signs of mortality or morbidity
after 48 hours, although glutathione, a component of the
anti-oxidant defence system, was depleted in the gill, and
significant lipid peroxidation (LPO) was found in the
brain [146]. Both the liver and gills had decreased LPO,
possibly due to upregulation of repair enzymes [146]. Fol-
low-up studies on these fish exposures using suppressive
subtractive hybridization confirms the upregulation of
repair enzymes as well as inflammatory response genes
(data not yet published).
Filter-feeding organisms represent a unique target group
for nano-particle toxicology. In the aquatic ecosystem,
zooplankton and filter feeding invertebrates make up the
basis of food webs. Zooplankton, such as rotifers and
branchiopods, are so small (micron range) that they feed
on nano-sized materials, including bacteria, viruses and
organic macromolecules. At this nano-scale, water is a vis-
cous liquid and many filtering apparatuses strain nano-
sized particles based not only on size, but also on surface
chemistry [147]. Therefore changing nanomaterial surface
chemistry to make them more biocompatible could ulti-
mately lead to selective filtering and uptake by zooplank-
ton and other selective filter feeding invertebrates such as
the mole crab studied by Conova [147]. Any nano-sized
material can be selectively consumed by zooplankton due
to their size, or can be taken in by generalist filter feeders,
such as the bivalves. Special considerations in terms of
safety assessment should be made for the ability of zoo-
plankton and other filter-feeding invertebrates to con-
sume nano-sized materials. Many benthic invertebrates
specialize in ingesting sediment and extracting organic
material. The chemistry of most nano-materials predicts
that engineered nanomaterials will tend to adsorb to sed-
iments, creating another unique target group in the
Benthos.
In addition to filter feeders, nano-sized materials may also
influence Protozoan species. Recent studies have shown
that in cell culture, fibroblasts can alter their direction of
movement depending on whether nano-sized islands are
in the way [148]. Fibroblasts produced more filopodia to
sense and gather information, and were actively interact-
ing with the 10 nm × ~ 150 nm wide islands on the cell
culture plates [148]. The filopodia seem to be actively
involved in sensing both the physical and chemical nature
of the substrate, and filopodia direct the formation of
lamellipodia which ultimately leads the cell to the island
[148]. This type of interaction has been found in cell types
of various species and different nano-sized substrates
[148]. This implies that Rhizopoda, or other protist spe-
cies, which use pseudopodia for locomotion, may be able
to specifically interact with nanomaterials in their envi-
ronment.
An additional potential target group are the Photosyn-
thetic Primary Producers. Some impressive technologies
have been developed for more efficient solar cells based
on chlorophyll [149]. This technology is based on elec-
tron transfer from a synthetic chlorophyll analogue to a
C60 in a carbon paste. It would be prudent to investigate
whether fullerenes could also act as electron acceptors
from natural chlorophyll, and whether fullerene in the
environment could potentially uncouple photosynthesis.
This is purely speculative, and the use of fullerenes to
make more efficient solar cells would be extremely useful
in breaking the dependence on non-renewable fossil
fuels.
5.2 Bactericidal properties of nanomaterials
Several studies have reported bactericidal properties of
fullerenes or modified fullerenes. Both gram negative and
gram positive bacteria are highly sensitive to nC60, with a
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48 hour LC50 in the 20 ppb range [150]. Dr. Pedro Alvarez
(Rice University) is following up on this observation and
is currently investigating the effects of nC60 on bacterial
communities. In the study of largemouth bass described
above, it was noticed that exposure water was visibly more
clear than control water, indicating that beneficial bacteria
were most likely eliminated from the water [146]. Modi-
fied fullerenes have also been specifically engineered to be
anti-microbial [26], which would be beneficial in Medi-
cine, but could potentially be detrimental if released into
the environment, similarly to what is currently occurring
with overuse of traditional antibiotics.
Not all nanomaterials are bactericidal. For example, un-
coated and peptide-wrapped (as prepared by methods of
Dieckmann et al. 2003)[151] and ssDNA-wrapped Single-
Walled Carbon Nanotubes (SWNT) [152] are not toxic to
E. coli up to ppm levels, which are the limits of their water
solubility (Dr. Rockford Draper, University of Texas, per-
sonal communication). Therefore a broad generalization
that all nano-materials are bactericidal is not appropriate.
Each material and coating must be assessed on an individ-
ual basis for their potential to disrupt microbial ecology,
and also for their potential environmental toxicity.
5.3 Stability of engineered nanomaterials and weathering 
of surface coatings
Fullerenes, nC60, are stable in aqueous medium up to 10
mM NaCl and 10 mM NaN3 solution [153], and in up to
3% NaCl solution and in Houston-area low-salinity
bayou water which contains tannins (personal communi-
cation, Mason Tomson, Rice University). We have also
found that nC60 is stable in Reconstituted Hard Water,
consisting of 192 mg/L NaHCO3; 120 mg/L CaSO4-2H2O;
120 mg/L MgSO4; 8 mg/L KCl, pH 8.5 [146]. Other nano-
materials have wide solubilities in water, biological fluids,
and other solvents [152,154-159], and would be expected
to be soluble in environmentally relevant conditions and
inside organisms. Of particular interest are nanomaterials
that are to be used for personal care products such as sun-
screens [160]. Other active ingredients in sunscreens and
personal care products have been found at measurable
levels in lakes in Europe and elsewhere, at levels where
impacts on wildlife is to be expected [161]. If engineered
nanomaterials are introduced in widely used personal
care products, they will certainly enter the environment as
well.
Nano-sized particles do not move far in environmental
conditions. Studies have shown that size correlates with
movement, where smaller nano-sized particles are easily
adsorbed onto surfaces of sand grains and are therefore
immobilized [162]. Biological transport could still occur
from ingested sediments, but physical movement of
nano-sized materials is restricted by its small size and pro-
pensity to adsorb onto surfaces.
5.4. Impact of surface modifications
Two ways to modify nanomaterials to make them more
biocompatible and less toxic are by the use of various
coatings and by covalent surface modifications. Although
this is a valuable exercise in the laboratory, some studies
have shown that these coatings and covalent surface mod-
ifications can be altered under UV exposure or exposure to
oxygen in the air, and cause rapid cytotoxicity [163,164].
Therefore, although coatings and surface modifications
may be critically important in drug-delivery devices, the
likelihood of weathering under environmental conditions
makes it important to study toxicity under UV and air
exposure conditions. This is similar to the problem of
studying polycyclic aromatic hydrocarbons (PAHs) in the
laboratory, where UV-exposure activates PAHs and makes
them more toxic (for examples, see [165,166])
5.5 Use of nanomaterials in bioremediation
This potential problem of UV activation can also be
turned into a potential benefit. For example, one can use
the photoactivity of nanomaterials for bioremediation.
Studies with UV-irradiated TiO2 showed promise in
removing organics from phenol solutions [167]. Others
have also used nanomaterials for bioremediation. This
included the removal of various organics (phenol, p-nitro-
phenol, salicylic acid) using nano-TiO2 [168]; the decom-
position of a carbothioate herbicide (Molinate) by zero-
valent iron [169]; the removal of hormones (E2, T, E1, P)
via nano-filters due to adsorption to the large nano-filter
surface area [170]; the removal of PAHs by amphiphilic
polyurethane (APU) Nanoparticles [171]; and the
removal of phenanthrene from aquifer material by
amphiphilic polymer particles [172]. Bioremediation has
also been field tested, where nanoscale redox active bime-
tallic (Fe/Pd) particles were able to reduce trichloroethyl-
ene contamination up to 96% in field trials. There are
likely other bioremediation uses of nanomaterials, and
this is not an exhaustive list.
Although nanomaterials may be used for bioremediation,
a cautionary note should be made about injecting
lipophilic, redox active compounds into the environment.
The impact on non-charismatic meiofauna (as opposed to
charismatic megafauna at which most of our environmen-
tal legislation is aimed) needs to be considered. In addi-
tion, as noted by Lecoanet and Wiesner (2004) [162],
nanosized materials may not migrate through soils at
rapid enough rates to be valuable in bioremediation.
Future laboratory and field trials will help clear up the line
between bioremediation and biocontamination.
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Summary
Production of engineered nanomaterials on the order of
thousands of tons by 2007 makes it very likely that these
materials will enter the environment through production,
manufacture, use, or disposal of products. There is an
almost complete lack of data on bioaccumulation, bio-
toxicity and biodegradation of NP in environmentally rel-
evant species. There is also limited study of the weathering
potential of both coatings and covalent surface modifica-
tions. Early studies indicate the fullerenes and their deriv-
atives may be toxic in some species (fish, daphnia and
bacteria), while other nanomaterials (SWNT) have lim-
ited toxicity to bacteria. Therefore no blanket statements
about toxicity of nano-sized materials can be made at this
time. Potential benefits of nanotechnology in the environ-
ment include uses in bioremediation and increasing effi-
ciency of fuel cells and solar cells to decrease our
dependence on fossil fuels (which have known toxic
impacts on the environment).
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